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  Flux  of  deoxyribonucleotides  between  mitochondria 
























This  Ph.D.  thesis  is  based  on  work  carried  out  at  the  Department  of  Science, 
Systems  and  Models  at  Roskilde  University  from  2005  to  2009  under  the 
supervision of Professor Lene Juel Rasmussen. 
The  Ph.D.  project  has  aimed  to  provide  information  about  the  involvement  of 
DNA  precursors,  deoxyribonucleotide  triphosphates  (dNTP),  in  maintaining 
genomic stability. The primary focus of the study has been on the regulation of 
dNTP  in  cells with  dysfunctional mitochondria.  Furthermore,  the  role  of  dNTP 
levels  following DNA damage  has  been  studied  in  Saccharomyces  cerevisiae.  In 
addition I have worked on an In Silico sorting strategy to predict mitochondrial 
proteins amongst hypothetical proteins and finally I have demonstrated that the 
polycyclic  aromatic  hydrocarbon  anthanthrene  is  mutagenic  despite  general 
belief. 
The results are presented in three published papers (Paper I, II, and V) and two 
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separated  from  the  rest  of  the  cell.  In  mammals,  mitochondria  furthermore 






mitochondrial  dNTP pool.  This  strongly  suggests  that mitochondria of  dividing 
cells  are  not  dependent  on  mitochondrial  synthesis  of  dNTP.  Conversely 
mitochondrial dysfunction caused by depletion of the mitochondrial genome has 




In  Saccharomyces  cerevisiae  an  increase  in  dNTP  pools  following DNA  damage 
increases mutation  frequencies,  but  also  cell  survival.  Increased  survival  after 











during  incomplete  burning  of  coal,  oil  and  gas.  Previously  it was  believed  that 
only  PAHs  with  either  bay  or  fjord  motifs  were  mutagenic.  We  have 
demonstrated that the PAH anthanthrene induces DNA damages despite it lack of 










En  tilgængelig  og  balanceret  forsyning  af  deoxyribonucleotide  triphosphater 
(dNTP) er afgørende for genomiske stabilitet. Mitokondrier er unikke organeller 
idet de  indeholder et mitokondrielt  genom og en dNTP pool  som er adskilt  fra 
resten  af  cellen.  I  pattedyr  indeholder  mitokondrier  desuden  specifikke 





menneskelige  kolon  cancerceller  i  stand  til  at  opretholde  en  balanceret 
mitokondriel dNTP pool. Dette tyder på at mitokondrier i delende celler ikke er 
afhængige af den mitokondrielle syntese af dNTP. En mitokondriel dysfunktion, 
forårsaget  af  en  mangel  af  det  mitokondrielle  genom,  påvirker  omvendt  den 
cytosoliske dNTP pool og skaber både en ubalance og et fald i koncentrationen af 
dNTP.  Samtidig  med  en  dNTP  ubalance,  blev  forekomst  af  kromosomal 










på  at  finde  de  kandidater,  som  mest  sandsynligt  er  udtrykt  i  den  undersøgte 
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kontekst.  Selv  om  vi  har  undersøgt  tilstedeværelsen  af  ukarakteriserede 
mitokondrielle  proteiner  i  mennesker,  kan  den  beskrevne  sorterings  strategi 
også anvendes i andre organismer og for andre organeller. 
Polycykliske  aromatiske  kulbrinter  (PAH)  er  miljøforurenende  stoffer,  der 
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Mitochondrial dysfunction has been demonstrated  to result  in decreased  levels 
as well as imbalance of cellular deoxyribonucleotide triphosphate (dNTP) pools 
in  dividing  human  cells. While  such  an  affect  on  the  dNTP  pool  are  known  to 




does  not  induce  imbalances  of  cytosolic  dNTP by deficient  export  or  excessive 
import  of  deoxyribonucleotides  to  the  organelle.  It  is  more  likely  that 
dysfunctional  mitochondria  mediate  inhibition  of  the  de  novo  synthesis  of 
precursors  of  dNTP  through  inhibited  activity  of  the  mitochondrial  enzyme 
dihydroorotate  dehydrogease  or  by  a  decreased  production  of  mitochondrial 




The biological  role of  a  link between mitochondria and  regulation of  the dNTP 
levels is unknown, but could participate in the progress of apoptosis. In the case 





Mitochondria  are  semiautonomous  organelles  present  in  almost  all  eukaryotic 
cells ranging  from a single copy to several  thousands.  Important mitochondrial 
functions  include ATP production  by  oxidative  phosphorylation, β‐oxidation  of 
fatty  acids  and  metabolism  of  amino  acids  and  of  lipids.  Furthermore, 
mitochondria  have  a  prominent  role  in  apoptosis.  Most  human  cells  contain 
between 103 and 104 copies of circular mitochondrial DNA (mtDNA) molecules 
[Cummins 1998].  
The  organelle  is  double‐membrane  enclosed  and  an  electron  transport  chain 
(ETC)  maintains  an  electrochemical  potential  gradient,  between  the  inter‐
membrane space and the matrix of the mitochondria. The ETC is constituted of 
four membrane bound enzyme complexes (complex I‐IV),  two electron carriers 
(ubiquinon  and  cytochrome  c),  and  is  located  in  the  inner  membrane  of  the 
mitochondria. The most often mentioned utilizer of the electrochemical gradient 
is  the ATP synthase (complex V) generating ATP by oxidative phosphorylation. 
Mitochondrial  dysfunction  that  results  in  depolarization  of  the  inner 
mitochondrial membrane causes changes of cellular functions that can manifest 
as a variety of pathologies. When the electrochemical gradient is compromised, 
the  cell  suffers  from  lower  production  of  ATP  and  some  well  characterized 
pathologies resulting from a mitochondrial dysfunction are directly linked to an 
insufficient  ATP  production  [DiMauro  and  Schon  2003].  Mitochondria  contain 
genome(s), separate from the nuclear genome that encodes 37 polypeptides, 13 
of those encoding subunits, critical for ETC function [Wallace 1999; DiMauro and 




maternally  inheritance.  In  the  following  we  will  focus  on  mitochondrial 
dysfunction resulting in depolarization of the mitochondrial membrane, and any 
reference  to  mitochondrial  dysfunction  will,  unless  otherwise  stated,  mean 






available  for  mitochondria.  The  synthesis  of  mitochondrial  dNTP  occurs 
throughout  the  cell  cycle  whereas  synthesis  of  cytosolic  dNTP  is  restricted  to 
synthesis  in  proliferating  cells  and  little  or  no  synthesis  in  resting  or  non‐
proliferating cells. A balanced supply of dNTP is required for correct DNA repair 
and  replication  [Meuth  1989].  Imbalance  of  the  dNTP  pools  can  induce  base 
substitutions,  frameshift  mutations,  delay  of  replication  fork  progression  and 
DNA replication and enhance the frequency of fragile sites [Mathews et al., 2006; 
Ke  et  al.,  2005;  Reichard  1988;  Bebenek  and  Kunkel  1990;  Jacky  et  al.,  1983; 
Kunz and Kohalmi 1991; Wickremasinghe and Hoffbrand 1980; Golos and Malec 
1991].  We  have  recently  demonstrated  how  depletion  of  the  mitochondrial 
genome,  in two different human cancer cell  lines, results  in decreased  levels as 
well as imbalance of cellular dNTP pools when the cells are in exponential phase. 
Imbalanced  cytosolic  dNTP  pools  causes  genetic  instability  in  the  nuclear 
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genome  and  in  accordance, we  show  that mitochondrial  dysfunction  results  in 




In  this  review  we  describe  possible  pathways,  whereby  a  mitochondrial 
dysfunction can influence regulation of the cytosolic dNTP levels. These include a 
reduced  production  of  precursors  for  de  novo  synthesis  of  dNTP mediated  by 
inhibition  the  activity  of  the  mitochondrial  localized  enzyme  dihydroorotate 
dehydrogenase  or  an  insufficient  production  of  one  carbon  units  from  the 
mitochondria. Furthermore, we will describe whether mitochondrial dysfunction 
can result in an erratic regulation of NO produced in mitochondria, affecting both 
intra  mitochondrial  and  cytosolic  regulatory  pathways  important  for  de  novo 
dNTP synthesis. 
 We  will  briefly  suggest  a  role  for  the  link  between  mitochondria  and  dNTP 
regulation in a non‐pathological context and discuss the biological role of the link 
between dysfunctional mitochondria and a dNTP  imbalance  in  the propagation 
of cancer. 
 
Flux  of  deoxyribonucleotides  between  mitochondria  and  the  cytosol  is 
unlikely to cause a cytosolic dNTP imbalance  
The replication of mtDNA is not synchronized with the synthesis of nuclear DNA 




the  two  rate‐determining  deoxyribonucleoside  kinases:  thymidine  kinase  2 
(TK2)  and  deoxyguanosine  kinase  (dGK)  yielding  deoxyribonucleoside  mono‐
phosphates  (dNMP),  which  in  turn  can  be  further  phosphorylated  to  their 
corresponding di‐ and tri phosphates (dNDP and dNTP) or be dephosphorylated 
to  deoxyribonucleosides  again  by  mitochondrial  deoxyribonucleotidases 
[Eriksson  et  al.,  2002;  Bianchi  and  Spychala  2003].  The  mitochondrial  inner 
membrane  is  impermeable  to charged molecules and consequently,  there  is no 
direct  exchange  of  deoxyribonucleotides  between  the  cytosolic  and 





Export  of  deoxyribonucleotides  from  the  mitochondrial  to  the  cytosolic 
compartment has been demonstrated. In cultured cells lacking essential enzymes 
of the cytosolic salvage pathway, an exogenous source of labeled thymidine was 
imported  into  the  mitochondria  and  phosporylated  exclusively  by  the 
mitochondrial  salvage  pathway,  resulting  in  a  mitochondrial  pool  of  labeled 
dTTP.  An  efflux  of  labeled  dTTP  to  the  cytosolic  compartment  and  an 
incorporation of labeled dTTP into nDNA could be demonstrated, confirming an 
export  of  mitochondrial  deoxyribonucleotides.  Even  though  the  cells  lacked  a 
functional  cytosolic  salvage pathway  the  contribution of  the  labeled dTTP only 
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constituted  a  fraction  of  the  cytosolic  pool  of  dNTP,  indicating  a  strong 
dominance of dNTP produced by  the de novo pathway, demonstrating  that  the 
mitochondrial contribution to the cytosolic pool of dNTP is negligible [Pontarin 
et  al.,  2003].  Conversely,  import  of  the  precursor  of  dTTP,  deoxythymidine 
mono‐phosphate  (dTMP),  has  been  demonstrated  from  the  cytosolic‐  to  the 
mitochondrial  compartment  using  pulse‐chase  experiments  with  radioactively 
labeled dTMP. Within  the  organelle,  some of  the dTMP was phosphorylated  to 
dTDP and dTTP. The mitochondrial import of cytosolic dTMP, was unaffected by 
inhibition of mitochondrial ATP production or  inhibition of  the ETC, which are 
hallmarks  of  depolarization  of  the  mitochondrial  membrane  [Ferraro  et  al., 
2006].  
In non‐dividing tissue, loss of function mutations of TK2 has been demonstrated 
to  result  in  mitochondrial  dNTP  imbalance  and  consequently  deletions  and 
depletions of mtDNA [Saada et al.,2001]. Furthermore, even subtle  impairment 
of  TK2  activity  has  been  reported  to  result  in  decreased  mitochondrial  dNTP 
pool  [Wang  et  al.,  2003].  Using  a  human  cervical  cancer  cell  line  that  can  be 
induced to express lower levels of TK2, it was possible to reduce the activity of 
TK2  in  the cell with 47% [Desler et al., 2006]. The activity was assayed by  the 
ability of TK2  to phosphorylate  thymidine‐β‐D‐arabinoside.    In dividing cells,  a 
reduced  activity  of  TK2  induced  a  minor  increase  of  the  mitochondrial  dCTP 
pool, while  the dTTP, dATP and dGTP pools where unaffected. This  indicates a 
mitochondrial  import of  cytosolic deoxyribonucleotides. However,  in  cells with 
reduced TK2  activity,  no difference was measured  in  the  cytosolic  dNTP pools 




Deoxyribonucleotides  synthesized  by  the  mitochondrial  salvage  pathway  are 
exported to the cytosol, however, the mitochondrial contribution to the cytosolic 
dNTP  pool  has  been  demonstrated  to  be  negligible  [Pontarin  et  al.,  2003]. 
Furthermore,  the  import  of  dTMP  through  the  mitochondrial  membrane  has 
been demonstrated not  to be affected by a depolarization of  the mitochondrial 
membrane  induced  by  various  respiratory  inhibitors  [Ferraro  et  al.,  2006]. 
Finally,  reduced activity of TK2,  and  thereby  increased  cellular dependence on 
cytosolic  dNTP,  does  not  affect  the  cytosolic  pool  of  dNTP  in  dividing  cells 
[Desler  et  al.,  2006].  Together  this  strongly  indicates  that  in  dividing  cells,  a 
mitochondrial  dysfunction  is  unlikely  to  cause  a  cytosolic  dNTP  imbalance  by 
deficient export or excessive import of deoxyribonucleotides.  
 
Dihydroorotate  dehydrogenase  links  mitochondria  to  the  de  novo 
pyrimidne biosynthesis 
The  flavoenzyme  dihydroorotae  dehydrogenase  (DHODHase)  catalyzes  the 




membrane of  the mitochondria with  the active site  facing  the  inner membrane 
[Jones  1980;  Rawls  et  al.,  2000].  DHODHase  is  functionally  connected  to  the 
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electron transport chain by a flavin prosthetic group that couples dihydroorotate 
oxidation  to  respiratory  ubiquinone  reduction  [Bader  et  al.,  1998].  From 
ubiquinol,  the  reduced  form  of  ubiquinone,  the  flow  of  electrons  continues 
through the electron transport chain. 
As  a  result  of  the  connection  between  DHODHase  and  the  electron  transport 
chain, it has been suggested that any dysfunction of the electron transport chain 




been  suggested  that  mitochondrial  dysfunction  can  lead  to  imbalance  of  the 
cytosolic  dNTP  pool  and  this  is  caused  by  inhibition  of  the  DHODase  [Singh 
2004].  The  relationship  between  DHODHase  and  the  ETC  has  been  described 
using  the  two  ETC  inhibitors,  rotenone  and  sodium  cyanide  on  mitochondria 
isolated  from  rat  liver,  kidney  and  heart.  Rotenone  inhibits  the  transfer  of 
electrons  from  complex  I  of  the  ETC  to  ubiquinone,  whereas  sodium  cyanide 
inhibits  complex  IV.  In  isolated  mitochondria,  treatment  with  sodium  cyanide 




correct  function  of  DHODHase,  but  also  for  correct  localization  of  the  protein. 
DHODHase  is  encoded  by  nDNA  and  the  import  into  the  membrane  of  the 
mitochondria is dependent on a targeting signal in the N‐terminal segment of the 
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protein.  It  has  been  demonstrated  that  import  of  rat  DHODHase  into  yeast 
mitochondria was  abolished by  an uncoupling of  the mitochondrial membrane 
indicating  the  requirement  of  a membrane  potential  for  correct  positioning  of 
DHODHase [Rawls et al., 2000]. 
The  importance  of  a  functional  DHODHase  for  the  de  novo  synthesis  of 
pyrimidines is emphasized by the effect of inhibitors of DHODHase. Leflunomide 
and  brequinar  are  two  examples  of  DHODHase  inhibitors  that  bind  to  the 
quinone‐binding  site  of  DHODHase,  thereby,  blocking  interaction  between 
ubiquinone  and  the  flavin  prostethic  group  of  DHODHase  [Liu  et  al.,  2000]. 
Treatment of human lymphocytes with leflunomide or brequinar arrest the cells 
in  G1  phase  and  inhibit  both  RNA  and  DNA  synthesis  [Chong  et  al.,  1996; 
Rückermann  et  al.,  1998;  Greene  et  al.,  1995].  The  inhibitory  effects  are 
suppressed by addition of uridine, which can be salvaged to UMP whereby the de 
novo  synthesis  of  pyrimidines  is  by‐passed.  Treating  the  human  leukemic  cell 




Chloramphenicol  is  an  antimicrobial  agent  that  inhibits  mitochondrial  protein 
synthesis  [Storrie  and  Attardi  1973].  Treatment  of  cells  with  chloramphenicol 
therefore  mimics  mitochondrial  dysfunction  and  impaired  ETC  activity. 
Treatment  of  chick  embryo  cells  with  chloramphenicol  inhibits  activity  of 
DHODHase  as  well  as  cell  growth  [Grégoire  et  al.,  1984].  Growth  of  Ehrlich 
Ascites  tumor  cells  under  hypoxic  conditions  inhibited  the  ETC  and  caused 
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reduced  activity  of  the  DHODase  and  G1  arrest  [Löffler  1980].  For  both  the 
chloramphenicol  treated  chick embryo  cells  and hypoxic Ehrlich Ascites  tumor 
cells, growth inhibition was reversed by addition   of pyrimidines to the growth 
media.  This  indicates  that mitochondrial  dysfunction  affecting  the  ETC  has  an 




Mitochondrial  dysfunction  affecting  the  ETC  is  likely  to  cause  decrease  of 
pyrimidine  nucleotides  mediated  by  an  inhibition  of  DHODHase  activity.  As  a 
result of the decreased levels of cytosolic pyrimidine nuclotides, an inhibition of 
both RNA and DNA synthesis is likely to entail. Imbalanced dNTP pool resulting 
from  inhibition  of  DHODHase  has  been  proposed  [Singh  2004].  However,  no 









synthesized  from  glycolysis  via  3‐phosphoglycerate.  Serine  is  reversible 
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converted into glycine in a process catalyzed by serine hydromethyltransferase 
(SHMT)  where  a  methyl  group  is  transferred  from  serine  to  tetrahydrofolate 
(THF),  yielding  glycine  and  5,10‐methyleneTHF  [Schirch  1982].  There  are  two 
isoenzymes  of  SHMT,  a  cytosolic  (cSHMT)  and  a  mitochondrial  (mSHMT) 
[Garrow  et  al.,  1993].  It  is  generally  believed  that  the  process  catalyzed  by 
mSHMT  is  the  primary  pathway  for  conversion  of  serine  to  glycine  and  5,10‐
MethyleneTHF.  This  is  substantiated  by  studies  using  Chinese  Hamster  Ovary 
(CHO)  cells  lacking  mSHMT  activity  where  a  15‐fold  accumulation  of 
intracellular  serine  concentration  over  wildtype  CHO  cells  has  been 
demonstrated.  Despite  the  increased  concentration  of  serine,  the  net  flux 
through  cSHMT  was  demonstrated  to  be  in  the  direction  of  serine  synthesis 
[Narkewicz et al., 1996]. Furthermore, CHO cells deficient in mSHMT activity are 
glycine  auxotrophs  [Pfendner  and  Pizer  1980],  and  the  auxotrophy  can  be 
suppressed by transfection with a human version of mSHMT, suggesting that the 
primary role of mSHMT but not cSHMT is to generate glycine [Stover et al.,1997].  
Within  the  mitochondrial  compartment,  5,10‐methyleneTHF  is  converted  into 
formate in a series of enzymatic conversions initiated by the conversion of 5,10‐
methyleneTHF  into  5,10‐methenyltetrahydrofolate  in  a  NAD+  dependent 
reaction  catalyzed  by  methylenetetrahydrofolate  dehydrogenase  (methylene‐
THF  dehydrogenase).  Formate  can  be  exported  from mitochondria  to  cytosol, 
where  it  is  converted  to  10‐formyltetrahydrofolate  (10‐CHO‐THF)  in  an  ATP 
dependent  reaction  catalyzed  by  10‐formyltetrahydrofolate  synthase.  10‐CHO‐
THF  is  an  essential  one‐carbon  unit  donor  for  the de  novo  synthesis  of  purine 
nucleotides,  requiring 2 moles of 10‐CHO‐THF per mole of purine ring  formed. 
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[reviewed  in  Appling  1991;  Depeint  et  al.,  2006].  A  supply  of  mitochondrial 
produced  formate  is  not  an  indispensable  carbon  source  for  the  synthesis  of 
purine  nucleotides,  however,  in  murine  fibroblasts  where  mitochondrial 
production of formate is blocked, a supplement of formate was demonstrated to 




and DNA and  their origin could be  traced  to originate  from serine  imported  to 
the mitochondria and exported as formate [Patel et al., 2003; Fu et al., 2001].  
The  mitochondrial  permeability  transition  pore  (PT  pore)  allows,  in  its  open 
state, diffusion of molecules with molecular masses less than 1.5 kDA. The exact 
molecular  composition  of  the  PT  pore  remains  uncertain,  although,  both  the 
adenine  nucleotide  translocase  and  cyclophilin  D  are  believed  to  be  key 
structural components.  [Reviewed  in  Javadov and Karmazyn 2007]. Opening of 
the  PT  pore  has  several  consequences  for  the mitochondria,  one  of which  is  a 
loss  of  mitochondrial  inner  membrane  potential  [Zamzami  et  al.,  2005]. 
Furthermore,  it has been demonstrated that opening of the PT pore mediates a 
release  of  mitochondrial  NAD+  to  be  hydrolyzed  by  a  NAD+  glycohydrolase, 
localized  outside  the matrix,  resulting  in  depletion  of mitochondrial  NAD+  [Di 
Lisa et al., 2001]. Opening of the PT pore is regulated by several factors including 
Ca2+,  matrix  pH  and,  most  importantly  in  this  context,  a  depolarization  of 
mitochondrial potential [Bernadi 1992; Bernadi et al., 1994]. 
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The  mitochondrial  conversion  of  5,10‐methyleneTHF  into  5,10‐
methenyltetrahydrofolate  is  a  NAD+  dependent  reaction  and  is,  furthermore, 
suggested  to  be  sensitive  to  the  ATP/ADP  ratio  in  the matrix.  It  is,  therefore, 
conceivable  that  mitochondrial  dysfunction  leading  to  decreased  ATP  levels 
and/or a premature opening of  the PT pore  can  result  in  inhibition of  formate 
produced  in  mitochondria,  which  inhibits  the  de  novo  synthesis  of  purine 
nucleotides and deoxyribonucleotides. By comparing human osteosarcoma cells 
devoid of mtDNA with their parental mtDNA containing cells,  it was  found that 
both  cell  lines  grew  equally  well  in  complete  and  glycine‐deficient  media, 
demonstrating that the cells without mtDNA were not glycine auxotrophs [Patel 
et  al.,  2003].  In  the  previously  described  case  of  a  complete  inhibition  of 
mitochondrial formate production, cell growth was a two‐fold slower [Patel et al 
2003]. It  is possible that a partial  inhibition of mitochondrial formate synthesis 







(mtNOS)  is  a  constitutively  expressed  enzyme  that  generates  NO  in  a  Ca2+ 
dependent reaction. Furthermore, judging from proven properties of other nitric 
oxide  synthases,  production  of NO by mtNOS  is  likely  regulated  by  acetylation 
and  phosphorylation  of  the  enzyme  [reviewed  in  Haynes  et  al.,  2004].  The 
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enzyme  is  located  in  the  inner  membrane  of  the  mitochondria,  [Tatoyan  and 
Giulivi 1998]. Within  the mitochondrial membrane, mtNOS physically  interacts 







NO  levels  [Beuneu  et  al.,  2000;  Brookes  et  al.,  1999].  Both  the  localization  of 




Nitric  oxide  produced  by  mtNOS  is  most  likely  not  constricted  to  the 
mitochondria,  but may  serve  a  role  in  the  cytosolic  compartment. Efflux of NO 
from  the  mitochondria  to  the  cytosol  has  been  demonstrated.  This  efflux  is 
correlated  with  the  membrane  potential  of  the  mitochondria  and  has  been 
hypothesized  to  function as  a mitochondrial  signal  to  the  cytosol,  reporting on 
the  energy  status  of  the  mitochondria  [Boveris  et  al.,  2006;  Valdez  2006].  By 
using mitochondria extracted  from different  rat  tissue,  the  fraction of  cytosolic 




and minimal  after  treatment  of  CCCP.  Treatment  with  oligomycin  inhibits  the 
ATP  synthase  and  produces  a  hyper  polarization  of  the  mitochondrial 
membrane. Conversely, treatment with CCCP uncouples the membrane. This led 
to  the hypothesis  that mtNOS  is a voltage dependent enzyme, whose activity  is 
regulated  by  mitochondrial  membrane  potential  [Boveris  et  al.,  2006;  Valdez 
2006].  Very little is known about any possible deregulation of mtNOS resulting 
from  mitochondrial  dysfunction.  Judging  from  mtNOS  activity  after  treatment 
with CCCP and oligomycin  it  can be  assumed  that  a mitochondrial  dysfunction 




from animals  subjected  to  normoxic  conditions  [Lacza et  al.,  2001].  This  could 
indicate  that  the  regulation  of  mtNOS  caused  by  a  mitochondrial  dysfunction 
might prove to be more complex. 
The role of an efflux of NO from the mitochondria  into the cytosol  is unknown, 
however,  it  has  been  suggested  that  it  may  serve  a  regulatory  role  in  cell 




and  depending  on  the  amount  of  NO  emanating  from  the mitochondria,  these 
could  provide  a more  direct  relationship  between  the mitochondria  and  dNTP 
balance.  During  the  de  novo  pathway  the  reduction  of  ribonucleotides  to  2'‐
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deoxyribonucleotides  is  catalyzed  by  the  rate  limiting  enzyme  ribonucleotide 
reductase. The reductase constitutes the major regulator of the de novo pathway 
[Jordan  and Reichard,  1998] mediating  a  reduction  of  the  2'‐hydroxy  group  in 
the  ribose  of  the  ribonucleotides  [Larsson  and  Reichard,  1966].  The  resulting 
deoxyribonucleotides dADP, dCDP and dGDP undergo phosphorylation yielding 
the  corresponding dNTPs;  however  dTTP  is  synthesized  from dCDP  and dUDP 
and requires additional steps. Ribonucleotide reductase has been demonstrated 




al.,  2004].  Inhibition  of  the  reductase  by  NO  was  demonstrated  to  induce  a 








hypothesize  that  this  link  is  most  likely  in  effect  during  the  progress  of  an 
apoptotic  event.  Mitochondria  have  an  essential  role  in  the  progression  of 
apoptotic  signals mediated  by  the  released mitochondrial  proteins  that  trigger 
activation of caspase family proteases or disruption of the electron transport and 
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mitochondrial  membrane  potential.  Further  progress  of  apoptosis  is 








existence  of  a  PT  pore  has  been  suggested  to  cause  loss  of  transmembrane 
potential [Zamzami et al., 2005]. Interestingly, it has been demonstrated that the 
depletion of mtDNA in human leukaemic lymphoblasts increase resistance to the 
apoptosis  inducing agent vinblastine. The  increase was  suggested  to be  caused 
by a disruption of the ETC, rather than the resulting lower levels of ATP, since an 
inhibition  of  the  ATP  synthase,  in  mtDNA  containing  cells,  did  not  increase 
resistance to vinblastine. This indicates that the mitochondrial inner membrane 
potential  is  important  for  the  progression  of  an  apoptotic  event  and 
demonstrates  a  correlation  between  the  fidelity  of mtDNA,  the  function  of  the 
ETC and the progress of apoptosis [Jia et al., 1997].  
An imbalance of the dNTP pool has been suggested to serve as an initiating factor 
in  the  pathway  of  apoptosis,  indicated  by  an  increase  of  apoptotic  events  in 
different  cell  lines  after  inhibition  of  dNTP  synthesis  and  alteration  of  dNTP 
levels  [Miyashita and Reed 1992; Oliver et al., 1993]. Accordingly,  treatment of 
hemopoietic  BAF3  cells  with  either  of  the  inhibitors  hydroxyurea  or 
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methotrexate  was  demonstrated  to  induce  apoptosis.  The  inhibitory  effects  of 
hydroxyurea  and methotrexate  are  directed  at  the de  novo  synthesis  of  dNTP. 
The increased number of apoptotic events resulting from an inhibition of the de 
novo pathway could be normalized by an addition of deoxyribonucleosides, and 
thereby  supplying  the  salvage  pathway  with  precursors  for  adequate  dNTP 
synthesis [Oliver et al., 1996]. During an apoptotic event, loss of transmembrane 
potential  has  been  demonstrated  to  be  important  for  the  continuation  of  the 
process. It is possible that the loss of potential have an inhibitory effect on both 
the  activity  of  DHODHase  and  the  production  of  mitochondrial  formate  as 







In  previous  work,  we  have  demonstrated  how  depletion  of  the  mitochondrial 
genome, in two different human cancer cell lines, results in decreased levels and 
imbalance of cellular dNTP pool [Desler et al., 2007]. This suggests a connection 
between  mitochondrial  dysfunction  and  an  erratic  regulation  of  the  cytosolic 
dNTP  levels.  We  argue  that  in  dividing  cells,  mitochondrial  dysfunction  is 
unlikely  to  cause  cytosolic  dNTP  imbalance  by  impaired  export  or  excessive 
import  of  deoxyribonucleotides.  In  this  review,  we  describe  three  candidate 
pathways,  whereby mitochondrial  dysfunction  can  cause  depolarization  of  the 
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mitochondrial  membrane  and  consequently  affect  the  regulation  of  cytosolic 
dNTP levels. These three pathways encompass (1) reduced activity of DHODHase 
resulting in decreased production of UMP and, thereby, reduction of pyrimidine 
nucleotides,  (2)  reduced  production  and  export  of  mitochondrial  one  carbon 
units  in  the  form  of  formate,  resulting  in  reduced  production  of  purine 
nucleotides, and (3) erratic regulation of NO produced in mitochondria, affecting 
both  intra mitochondrial  and cytosolic  regulatory pathways of dNTP synthesis. 
Even  though  these  three  pathways  are  the  most  likely  mediators  of  the  link 
between  mitochondria  and  regulation  of  cytosolic  dNTP  levels,  more 
experimental data is needed to elucidate this relationship. However, it can not be 




a  increased frequency of chromosomal  instability  in cell  lines devoid of mtDNA 




has  been  demonstrated  to  occur  in  human  osteosarcoma  cell  lines  devoid  of 
mtDNA.  Furthermore,  the  cells  were  demonstrated  to  have  tumorigenic 
properties  measured  by  an  increased  anchorage  independent  growth  when 
compared  to  parental  cells  with  functional  mtDNA.  It  was  reported  that  the 
reintroduction  of  functional  mitochondria  with  mtDNA  could  suppress  the 
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tumorigenic phenotype [Singh et al., 2005]. These observations and other, define 
a  role  for  dysfunctional mitochondria  in  the  progression  of  cancer.  Due  to  the 
known  mutagenic  effects  of  dNTP  imbalance,  it  will  be  important  to  further 
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THE ROLE OF MITOCHONDRIAL DNTP LEVELS IN CELLS WITH
REDUCED TK2 ACTIVITY
C. Desler, B. Munch-Petersen, and L. J. Rasmussen  Department of Life
Sciences and Chemistry, Roskilde University, Roskilde, Denmark
 Both the nuclear and mitochondrial DNA (mtDNA) depend on separate balanced pools of
dNTPs for correct function of DNA replication and repair of DNA damage. Import of dNTPs
from the cytosolic compartment to the mitochondria has been suggested to have the potential of
rectifying a mitochondrial dNTP imbalance. Reduced TK2 activity has been demonstrated to result
in mitochondrial dNTP imbalance and consequently mutations of mtDNA in non-dividing cells.
In this study, the consequences of a reduced thymidine kinase 2 (TK2) activity were measured in
proliferating HeLa cells, on both whole-cell as well as mitochondrial dNTP levels. With the exception
of increased mitochondrial dCTP level no significant difference was found in cells with reduced TK2
activity. Our results suggest that import of cytosolic dNTPs in mitochondria of proliferating cells can
compensate a TK2 induced imbalance of the mitochondrial dNTP pool.
Keywords Thymidine kinase 2; Mitochondrial dNTP imbalance; dNTP transport
INTRODUCTION
Imbalanced levels of dNTP result in misincorporation of nucleotides
into the DNA, frameshift mutations and stalling of replication fork.[1–3]
Mitochondrial dNTP pool imbalance has been demonstrated to induce
deletions and depletions in mtDNA,[4] which may cause a number of mito-
chondrial related diseases such as mitochondrial neurogastrointestinal en-
cephalomyopathy (MNGIE) and mtDNA depletion syndrome (MDS).[4,5]
Among the possible mediators of a mtDNA imbalance are dysfunctions
of either of the mitochondrial deoxyribonucleoside kinases: thymidine
kinase 2 (TK2) or deoxyguanosine kinase (dGK).[1,6]
Recently, the importance of dNTPs from the cytosol to the mitochondria
has been demonstrated.[7] Once putative function of this transport is to
maintain the balance of the mitochondrial dNTP pool. In nondividing tissue
Address correspondence to B. Munch-Petersen, Department of Life Sciences, Roskilde University,
DK-4000, Roskilde, Denmark. E-mail: bmp@virgil.ruc.dk
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though, loss of function mutations in either TK2 or dGK have been demon-
strated to result in a mitochondrial dNTP imbalance and the consequential
deletions and depletions of mtDNA,[1,6] indicating that import of dNTP to
the mitochondria is insufficient in these cells. The cytosolic dNTP levels in
proliferating cells are however approximately 10-fold higher compared to
the levels of nondividing cells.[8] The increased concentration of cytosolic
dNTP could allow a putative import of dNTP to the mitochondria from the
cytosol, which would contribute to the maintenance of the mitochondrial
dNTP balance in dividing cells.
In the present study, we have modelled a loss of function mutation in
TK2 by generating a cell line that can be induced to express lower levels
of TK2, and we have measured both the cytosolic and mitochondrial dNTP
levels in these proliferating cells.
MATERIALS AND METHODS
Transfection of conditional TK2 antisense plasmids: The doxycyline-
responsive (Tet-On) vector pTRE2 (Clontech, Medinova Scientific A/S,
Denmark) was used to construct a plasmid expressing the TK2 cDNA in
antisense orientation. HeLa cells were transfected with the plasmid using
Lipofectamine 2000 (Invitrogen, A/S, Denmark), according to manufac-
turer’s instructions. As selectable marker the plasmid has the puromycin
resistance gene and stable clones were selected by incubation in culture
medium containing 1 µg/ml puromycin for 10 days. Subsequently, the cells
where trypsinated and transferred to 24-well microtiter plates at a density
of 50 cells per well. The cells were further incubated 10 days in culture
medium without puromycin and finally 7 days in culture medium containing
1 µg/ml puromycin. At each treatment with puromycin, a control culture
containing HeLa Tet-On cells not transfected with plasmid, was grown at
similar conditions. Before the puromycin treatment was ended, it was made
sure that all cells in the control culture had succumbed to the treatment.
Thymidine kinase assay: The activity of TK2 was assayed by its unique
ability to phosphorylate thymine-β-D-arabinoside (Ara-T). TK2 phospho-
rylates AraT with 30–50% of its substrate specificity toward thymidine.[9]
Stably transfected HeLa cells was screened by growing cells for 1 week both
with and without doxycyline present the in growth media and comparing
the TK2 activity of the 2 as described in the following. Cells where lysed by
sonication and cell extracts were assayed by adding 15 µl cell extract to a
final volume of 50 µl reaction mixture containing: 50 mM Tris-HCl pH 7.5,
10 mM DTT, 2.5 mM ATP, 2.5 mM MgCl, 3 mg/ml BSA, 6 mM NaF, 0.5 mM
Chaps and 20 mM [3H] AraT (3 ci/mmol, Morevek Biochemicals, Inc.,
Brea, CA, USA). The mix was incubated at 37◦C, and 10 µl aliquots were
removed from the solution at 4, 8 12, and 16 minutes after reaction start, and
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spotted onto discs of Whatman DE81 filters. The filters were dried, washed
(3 × 10 minutes) with ammonium formate and 5 minutes with autoclaved
MilliQ water. Finally the filters were eluted in 500 µl of 0.1 M HCl and 0.2 M
KCl and the radioactivity quantified by scintillation counting.
dNTP determination: The whole-cell and mitochondrial dNTP levels
were measured using the method of Pontarin et al.[7] and Sherman and
Fyfe.[10]
Statistics: Single classification analysis of variance (ANOVA) was used to
test for differences in dNTP levels among the different cell lines. Assump-
tions of normality were checked by visual inspection prior to ANOVA. When
the ANOVA indicated significant differences, Tukeys honestly significant
method was used to test for differences between the dNTP pools of
individual cell lines.
RESULTS
Screening of HeLa cells expressing TK2 antisense RNA in the presence
of doxycycline revealed several clones with reduced TK2 activity. One clone
that showed approximately 47% reduction of whole-cell TK2 activity upon
treatment with doxycycline for a week was chosen for further analysis (data
not shown). This cell line was named HeLa TK2−.
The whole-cell dNTP levels were determined in HeLa TK2− cells grown
in the presence of doxycycline for a week, and compared with isogenic cells
grown in absence of doxycycline. As illustrated in Figure 1, the doxycycline
induced reduction of TK2 activity did not result in a significant difference
in dNTP levels compared to cells with a wild type TK2 activity. This indicates
FIGURE 1 The whole-cell levels of dNTP are measured for the dividing cell lines HeLa-TK2+ and HeLa-
TK2− (n = 12; error bars indicate SD).
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that reduced TK2 activity does not have an effect on the whole-cell dNTP
levels.
Similarly, when we determined the mitochondrial dNTP levels of cells
grown in the presence as well as the absence of doxycycline, the difference
in TK2 activity did not result in a significant difference in the mitochondrial
levels of dTTP, dATP and dGTP. The levels of dCTP were significantly higher
with an 1.4-fold increase in cells with a reduced TK2 activity (Tukey; n = 6;
p < 0.001) (Figure 2).
DISCUSSION
Even subtle impairments of the TK2 activity have been reported to have
an effect on the balance of the mitochondrial dNTP pool. A His-121 to
Asn substitution in human TK2 resulted in vitro in a normal activity with
dThd as substrate but a 70% reduced activity with dCyd.[11] Furthermore
nonreplicating fibroblast cell lines homozygous for the His-121 to Asn
TK2 mutation showed decreased levels of mitochondrial dNTP content
compared to control cell lines.[1] Our results indicate that a mitochondrial
dNTP imbalance is rectified in dividing cells by an import of dNTP from
the cytosolic pool. This confirms the initial theory of the potential of such a
transport brought forth by both Pontairn et al.[7] and Saada et al.[1]
The mitochondrial levels of dTTP, dATP, and dGTP are not altered by
a reduced activity of TK2. If the two salvage kinases TK2 and dGK were
the sole providers of mitochondrial dNTP, reduced levels of dCTP and
especially dTTP would be expected as a result of reduced TK2 activity. Since
no other mitochondrial mediators of dNTP synthesis have been identified,
FIGURE 2 The mitochondrial levels of dNTP are measured for the dividing cell lines HeLa-TK2+ and
HeLa-TK2− (n = 6; errorbars indicate SD).
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an import of dNTP is the most likely explanation for the normal levels of
dTTP, dATP, and dGTP observed in the TK2− cell line.
The significant increase of dCTP levels in response to a reduced TK2
activity is intriguing however the biological explanation and significance of
this remains unclear as TK2 also phosphorylates deoxycytidine.
A reduction of TK2 activity did not result in a significant difference
between the whole cell levels of dNTP from the levels in cells with wild type
TK2 activity. This indicates that the extra contribution needed to sustain
the mitochondrial dNTP levels are well within the capacity of the cytosolic
de novo and salvage synthesis of dNTP.
The rectifying effect of a dNTP import from the cytosol to the mi-
tochondria in dividing cells serves as an excellent explanation as to why
infants harbouring loss of function mutations in proteins governing the
mitochondrial dNTP balance, often escape related symptoms until reaching
a certain age. At this time many of the cells go into a nondividing state,
which results in a 10-fold decrease of the cytosolic dNTP levels. With the
decreased import of dNTP from the cytosol, the mitochondrial dNTP levels
become imbalanced resulting in accumulating deletions and depletion of
mtDNA giving rise to the symptoms of the patients.
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Abstract
Mitochondrial function plays an important role in multiple human diseases and mutations in the mitochondrial genome have been
detected in nearly every type of cancer investigated to date. However, the mechanism underlying the interrelation is unknown.
We used human cell lines depleted of mitochondrial DNA as models and analyzed the outcome of mitochondrial dysfunc-
tion on major cellular repair activities. We show that the deoxyribonucleoside triphosphate (dNTP) pools are affected, most
prominently we detect a 3-fold reduction of the dTTP pool when normalized to the number of cells in S-phase. It is known
that imbalanced dNTP pools are mutagenic and in accordance, we show that mitochondrial dysfunction results in chromoso-
mal instability, which can explain its role in tumor development. We did not find any straightforward correlation between ATP
levels and dNTP pools in cells with defective mitochondrial activity. Our results suggest that mitochondria are central play-
ers in maintaining genomic stability and in controlling essential nuclear processes such as upholding a balanced supply of
nucleotides.
© 2007 Elsevier B.V. All rights reserved.
DNA reKeywords: Mitochondrial disease; Cancer; Chromosomal instability;
1. Introduction
Mitochondria are present in almost all eukaryotic
cells and most human cells contain 103–104 mitochon-
dria, each with several copies of a 16.6 kbp circular
mitochondrial DNA molecule (mtDNA) [1]. Several fac-
tors can contribute to genomic instability of mtDNA such
as increased levels of reactive oxygen species (ROS)
that originate from the mitochondrion itself [2] or inac-
∗ Corresponding author. Tel.: +45 46742728; fax: +45 46743011.
E-mail address: ljr@ruc.dk (L.J. Rasmussen).
0027-5107/$ – see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.mrfmmm.2007.06.002pair; dNTP levels
tivation of nuclear genes encoding proteins essential for
mtDNA maintenance resulting in deletions in and deple-
tion of mtDNA [3–6]. One of the best-characterized
functions of mitochondria is the production of ATP by
oxidative phosphorylation. Of the 90 subunits compris-
ing the mitochondrial electron transport chain (ETC), 13
are encoded by the mitochondrial genome itself. Dys-
function of mtDNA, therefore, inhibits ATP production
and processes dependent on proper function of the ETC
[7].
Mutations in mtDNA are associated with cancer as
dysfunctional mitochondria have been reported in a
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idney, liver, lung, colon, gastric, brain, bladder, head
nd neck, and breast cancers [8–10]. It was recently
emonstrated that the invasive phenotype of human cells
epleted of mtDNA (0) could be reversed by intro-
ucing exogenous wildtype mitochondria (+) [11–13].
long these lines, it has been demonstrated that deple-
ion of mtDNA abolishes androgen dependence of
rostate cancer cells, removing the requirement of andro-
en for cell proliferation [14]. These results suggest
hat mitochondrial dysfunction contributes to develop-
ent of tumors. The molecular mechanism underlying
he association between mitochondrial dysfunction and
umorigenesis is largely unknown; however, our earlier
eports suggest that nuclear DNA repair pathways are
mplicated. We have shown that human cells depleted
f mtDNA (0 cells) have reduced repair of oxidative
NA damage, while yeast cells depleted of mtDNA have
ncreased mutation frequencies in the nuclear genome
15,16]. The mitochondria-mediated mutator phenotype
etected in yeast 0 cells can be suppressed by inactivat-
ng subunits of the error-prone DNA repair (Rev1, Rev3,
nd Rev7). Error-prone repair is involved in bypass of
everal types of DNA lesions that have the potential to
nhibit chromosome replication. In error-prone transle-
ion synthesis (TLS), a non-replicative DNA polymerase
eplaces the replicative DNA polymerases when these
tall at DNA lesions in the template strand [17,18].
herefore, one interpretation of our previous findings
s that mitochondrial dysfunction limits or decreases
uclear DNA repair resulting in unrepaired DNA lesions,
hich are subsequently converted into mutations by
LS. Such an increase in unrepaired DNA lesions could
e a result of impaired function of one or several of the
ajor cellular repair pathways such as nucleotide exci-
ion repair (NER), base excision repair (BER), mismatch
epair (MMR) and/or recombinational repair (RER) [19].
nother explanation for the mutator phenotype observed
n 0 cells [15] is that mitochondrial dysfunction gen-
rates excessive DNA damage that is converted into
utations by TLS. Increased error-prone bypass of DNA
esions has been suggested to be characteristic of imbal-
nced dNTP pools [20]. In yeast, DNA damage results
n increased dNTP levels and this dNTP imbalance
mproves cell survival, possibly because of more effi-
ient TLS [21]. A balanced supply of dNTP is required
or DNA synthesis and is crucial for correct DNA repair
nd replication [22,23]. Imbalance of the dNTP pools
as been shown to induce base substitutions as well as
rameshift mutations [20,24]. Furthermore, imbalance
f the dNTP pools causes delay of DNA replication
ork progression and enhances fragile sites where chro-
osomes are susceptible to breakage. Consequently,rch 625 (2007) 112–124 113
imbalance of the dNTP pools can promote chromosome
rearrangement, breakage, and loss [22,25–28].
Irrespective of the origin of the observed DNA muta-
tions they may be involved in activating proto-oncogenes
and/or inactivating tumor suppressor genes, leading to
genomic instability, which play an important role in
development of human cancer [29]. Studies have iden-
tified two pathways for carcinogenesis: the suppressor
pathway characterized by a significant degree of chro-
mosomal instability (CIN) and the mutator pathway
characterized by microsatellite instability (MSI) [30].
The CIN pathway is characterized by gross chromo-
somal rearrangements and translocations whereas the
MIN pathway is characterized by sequence instability
like point mutations and small insertion/deletions. The
MIN pathway is accompanied by mutational inactivation
of MMR genes that is believed to lead to an increased rate
of mutations in tumor suppressor genes and oncogenes
[31]. MIN and defects in MMR are hallmarks of certain
forms of colon cancers such as hereditary nonpolyposis
colorectal cancer (HNPCC). Conversely, 85% of colon
tumors are estimated to be correlated with a significant
degree of CIN as compared to normal cells. Two fea-
tures suggest that MIN and CIN are complementary and
functionally important for cancer development: CIN is
not observed in MIN-positive tumors, suggesting func-
tional equivalence, and both MIN and CIN appear to arise
early in tumorigenesis. Clearly, CIN may favor tumor
progression by enhancing loss of heterozygosity (LOH)
at tumor suppressor loci. However, the identity of genes
that may be responsible for CIN is not clear, although
abnormal mitotic function is likely to be involved [31]
and recently mitochondrial dysfunction has been added
to the list [12].
In order to further clarify the mechanism under-
lying mitochondria-mediated genomic instability, we
analyzed the status of major nuclear DNA repair activ-
ities in human cervical and breast cancer cells depleted
of mtDNA (HeLa 0 and MDAMB435 0 cells, respec-
tively). We measured cytosolic dNTP levels of these 0
cells and show that mitochondrial dysfunction does not
affect overall repair capacity when measured as the abil-
ity to repair endogenous damage of the nuclear genome.
However, our results show that mitochondrial dysfunc-
tion contributes to imbalanced nucleotide metabolism
and chromosomal rearrangements, which could explain
the mutator phenotype of 0 cells. The nature of genomic
instability observed in human 0 cells is similar to that of
the CIN pathway suggesting that mitochondria-mediated
mutagenesis does not involve MMR but rather repair
systems that generate breaks or gaps if not functioning.
These could include BER and RER activities. Our results
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also suggest that mitochondrial function is required
to prevent chromosomal translocations and rearrange-
ments, which are associated with a variety of human
diseases such as cancer [12].
2. Materials and methods
2.1. Cell cultures
0 Cell lines where produced from their parental + cell
lines according to [32,33]. The human HeLa +, HeLa 0,
MDAMB 435 + and MDAMB 435 0 cells were maintained
in DMEM with Glutamax (Invitrogen, GIBCO) supplemented
with 10% FBS (BioChrom AG), 1% Penicillin/Streptomycin
(Invitrogen, GIBCO), 2 mM Na-pyruvate and 4 g/ml uridine
unless otherwise stated. Cells were grown at 37 ◦C in a humid-
ified atmosphere containing 5% CO2 for a minimum of 9 days.
Cells were grown in 75 cm2 flasks and were split when approxi-
mately 80% confluent. They were removed by trypsin treatment
and washed twice with ice cold PBS. Cell concentration and
average cell volume were determined in a Z2 Coulter Counter
(Beckham Coulter).
2.2. Measurement of ATP levels
ATP levels were determined using the ATP reporter kit from
Molecular Probes according to manufacturers instructions. The
luminance of the luciferase-based reporter was measured in a
Synergy HT multidetection microplate reader (Bio-Tek).
2.3. Measurement of dNTP levels
The DNA polymerase assay is based on the assay origi-
nally designed by Solter and Handschumacher [34] and later
improved by [35]. In brief, 4 × 106 cells were centrifuged at
750 × g for 5 min and resuspended in 1 ml 60% methanol. The
suspension was incubated at −20 ◦C for 90 min, placed in a
heating block and boiled at 100 ◦C for 3 min in order to remove
remaining enzyme activity. The suspension was centrifuged at
17,000 × g for 15 min and the supernatant slowly frozen in liq-
uid nitrogen. Methanol was evaporated overnight using a vac-
uum pump and the residue was rehydrated in 300 l Ultra-pure
H2O (Invitrogen, GIBCO). Reaction mixtures (total volume of
100 l) contained 15 l cell extract, 50 mM Tris pH 8, 5 mM
MgCl2, 10 mM DTT, 1 unit Klenow polymerase (Fermen-
tas), 5 M template oligonucleotide, and 0.48 M [3H]-dATP
(21 Ci/mmol (Vitrax) for dTTP, dCTP and dGTP determina-
tions) or 0.11 M [3H]-dTTP (87 Ci/mmol (Perkin-Elmer) for
dATP determination). The solution was incubated for 30 min at
37 ◦C. Three 10 l aliquots were spotted onto Whatman DE81
paper discs, dried, washed (3 × 10 min) with 5% Na2HPO4,
and rinsed once with sterile water. The papers were transferred
to scintillation tubes and 0.5 ml of eluent (0.1 M HCl and 0.2 M
KCl) was added. The tubes were shaked for 30 min and 2.5 ml
of Eco-Scint was added. Radioactivity was measured in a 1219
Rackbeta liquid scintillation counter (WALLAC).rch 625 (2007) 112–124
2.4. Thymidine Kinase 1 (TK1) activity determination
1 × 106 cells were centrifuged at 1400 × g for 5 min and
resuspended in 100 l extraction buffer (50 mM Tris–HCl pH
7.5, 2 mM DTT, 5 mM Benzamidin, 0.5 mM PMSF, 50 mM
E-amino caproic acid, 5 mM EDTA, 10% Glycerol and 0.1%
Triton X-100). The suspension was homogenized by 3 × 5 s
sonication on ice with 1 min intervals. The homogenate was
examined microscopically to ensure complete breakage of cell
membranes and centrifuged at 15,000 × g for 10 min. The
activity of TK1 was assayed by its unique ability to phosphory-
late 3′-azido-2′,3′-deoxythymidine (AZT) [36]. One microlitre
of the supernatant was mixed with an assay mix solution to
a final volume of 50 l (50 mM Tris–HCl pH 7.5, 10 mM
DTT, 2.5 mM ATP, 2.5 mM MgCl2, 3 mg/ml BSA, 6 mM NaF,
0.5 mM Chaps and 15 M [3H]-AZT (1.8 Ci/mmol)). The
assay mix was incubated at 37 ◦C. At 4, 8, 12 and 16 min after
reaction start, 10 l aliquots were removed from the solution
and spotted onto Whatman DE81 paper discs. The filters were
dried, washed with 5 mM ammonium formate (3 × 10 min)
and once with autoclaved MilliQ water. The nucleotides were
eluted by shaking with 0.5 ml eluent (0.1 M HCl and 0.2 M
KCl) for 30 min, whereafter 2.5 ml of Eco-Scint (National
Diagnostics) was added. Radioactivity was measured in a 1219
Rackbeta liquid scintillation counter (WALLAC).
The protein concentration of each cell extract was deter-
mined by Bradford assay.
2.5. Cell cycle analysis with a fluorescence-activated cell
sorter
For cell cycle analysis, cells were prepared and stained
using the Absloute-S kit (Phoenix Flow Systems) according
to manufacturers instructions. The kit utilizes BrdU incor-
poration to determine the number of cells in S-phase. DNA
content was measured using a Becton Dickinson FACSCal-
ibur fluorescence-activated cell sorter (FACS), Cell QuestPro
software and WinList software.
2.6. Comet assay
A modified version [37] of single-cell gel electrophoresis
was used to measure DNA lesions resulting from endogenous
DNA damage. The modifications include reduced elec-
trophoresis (10 min at 300 mA) and the use of a Dialux 22EB
(Leica) microscope and Comet Assay III (Perceptive instru-
ments) software to analyze assayed cells and calculate comet
tail moment. Mean Tail Moment was calculated from the comet
tail moment of 50 randomly selected cells and each data point
consists of a triplicate of Mean Tail Moments. This value was
then used as a quantitative index of DNA breaks.2.7. Microsatellite instability (MSI) analysis
Cell lines were carried through approximately 25 pas-
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to 2 × 106 cells using the Genelute kit (Sigma) accord-
ng to manufacturers guidelines. Microsatellite analysis was
erformed as previously described [38] using the HNPCC
icrosatellite Instability Test kit according to manufacturers
nstructions (Roche). Analyzed microsatellite loci included
5S346 (APC), BAT25, BAT26, D17S250 (Mfd15CA) and
2S123. As starting material we used 100 ng genomic DNA
nd PCR products were analyzed on an ABI 377 sequence
nalyzer, and GeneScan 3.0 (Perkin-Elmer).
.8. Incision repair assay
Oligonucleotides were purchased from DNA Technology
Aarhus, Denmark) and 5′end-labeled using T4 polynucleotide
inase (MBI, Fermentas) and (32P)ATP (Amersham Bio-
ciences). Unincorporated radioactivity was removed with G25
pin columns.
Isolation of mitochondria was accomplished using a com-
ination of differential centrifugation and Percoll gradient
entrifugation employing a protocol modified from [39].
riefly, actively growing cells were washed once with ice cold
BS, pelleted and resuspended in M-SHE buffer (0.21 M man-
itol, 0.07 M sucrose, 10 mM Hepes (pH 7.4), 1 mM EDTA,
mM EGTA, 0.15 mM spermine, 0.75 mM spermidine, 5 mM
TT, 2 M PMSF, 2 g/ml Protease inhibitor cocktail Set III
CalBiochem)). The cell suspension was homogenized using
teflon-to-glass homogenizer and the mitochondrial fraction
as separated from the nuclear pellet. The supernatant contain-
ng the mitochondria was subjected to differential and Percoll
radient centrifugation and protein concentration was deter-
ined by the Lowry method. Purified mitochondria were stored
s pellets at −80 ◦C. Nuclear extracts were prepared in par-
llel with the mitochondrial isolation, according to modified
ersions of two protocols [40,41]. Briefly, the nuclear pel-
et (obtained during preparation of mitochondria) was treated
ith 10 mM Hepes (pH 7.9), 400 mM NaCl, 1.5 mM MgCl2,
.1 mM EDTA (pH 8.0), 0.5 mM PMSF, 20% glycerol, 0.1%
P40 and 2 g/ml Protease inhibitor cocktail Set III (Cal-
iochem) and subsequently subjected to centrifugation. The
upernatant was dialyzed against 50 vol.% of a buffer contain-
ng 20 mM Hepes pH 7.9, 20% glycerol, 0.1 M KCl, 0.2 mM
DTA, 0.5 mM DTT and 0.5 mM PMSF. Protein concentra-
ion was determined by the Lowry method and the purified
uclei were stored in aliquots at −80 ◦C. Glycosylase/AP-lyase
ctivity in nuclei and mitochondria was measured using an
ligonucleotide incision assay as previously described [42].
riefly, to disrupt intact mitochondria, these were resuspended
n a buffer containing 20 mM HEPES-KOH (pH 7.6), 1 mM
DTA, 2 mM DTT, 300 mM KCl, 5% glycerol, and 0.05%
riton X-100. The mitochondrial suspension was subsequently
iluted to a final concentration of 5 g/l protein and 100 mM
Cl. Nuclear and mitochondrial incision reactions (20 l) con-
ained 20 mM HEPES-KOH (pH 7.6), 5 mM EDTA, 5 mM
TT, 75 mM KCl, 5% glycerol, 0.1 mg/ml BSA, and 90 fmol
2P-labeled duplex oligonucleotide. Reaction mixtures were
ncubated at 37 ◦C for 1 h and then terminated by adding pro-rch 625 (2007) 112–124 115
teinase K and SDS to a final concentration of 0.2 mg/ml and
0.4%, respectively, and incubated for 15 min at 55 ◦C. FA-
loading dye (80% formamide, 10 mM EDTA (pH 8.0)) was
added to the samples, heated for 2 min at 95 ◦C and analyzed
on a 20% denaturing polyacrylamide gel containing 7 M urea.
The radioactively labeled DNA was visualized using a Personal
Molecular Imager® (BioRad) and quantified using Quantity
One software (BioRad). Incision activity was calculated as the
ratio of damage-specific cleavage product to the total product
and substrate in the reaction.
2.9. Chromosomal instability (CIN) assay
CIN assay was performed by Spectral Karyotyping anal-
ysis (SKY). After mitotic arrest for 2 h with Colcemid, cells
were harvested and treated with hypotonic solution according
to the standard protocol. Chromosome slides were prepared
using air-drying. After sequential digestion with RNAse and
pepsin according to the procedure recommended by Applied
Spectral Imaging, Inc. (ASI: Carlsbad, CA), the chromosomes
were denatured in 70% formamide and hybridized with human
SKY paint probes tagged with various nucleotide analogues
(i.e., a mixture of individual chromosomal DNAs prepared
by flow-sorting and PCR amplification) [12]. The multiple
fluorescence color images of chromosomes generated by Rho-
damine, Texas-Red, Cy5, FITC and Cy5.5 were captured
using a Nikon microscope equipped with a Spectral cube
and Interferometer module and analyzed using SKY View
software (Version 1.62). Chromosome number and chromoso-
mal rearrangements or alterations including simple balanced
translocation or unbalanced (or non-reciprocal) translocation,
deletion and duplication, were analyzed to determine the lin-
eage of individual knock-out cell lines, compared to the original
wild-type counterpart.
2.10. Statistical analysis
Single classification analysis of variance (ANOVA) was
used to test differences in dNTP pools and ATP levels between
cell lines. Assumptions of normality were checked by visual
inspection prior to ANOVA. When the ANOVA indicated sig-
nificant differences among the cell lines, Tukeys honestly
significant method was used to test for differences between
dNTP pools of individual cell lines.
3. Results
3.1. Depletion of mtDNA leads to reduced levels of
ATP
Damage to mtDNA causes reduced activity of the
ETC resulting in decreased ATP level, leaving glycolysis
as the sole source of ATP supply in human cells. Since
ATP is essential for multiple cellular processes, includ-
ing DNA precursor synthesis and DNA repair activity,
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Table 1
ATP levels in human cells with dysfunctional mitochondria
Cell line ATP concentration (mM)
HeLa MDAMB435
+ 1.44 ± 0.4 2.1 ± 0.2
0 0.36 ± 0.06 0.13 ± 0.02
+/0 ∼4 ∼16The ATP levels of HeLa and MDAMB435 (+ and 0) cells were
determined and +/0 reflects the ratio of ATP levels between + and
0 cells (n = 3).
we compared the level of ATP in 0 cells with the ATP
level of their corresponding parental + cell lines. Our
results show that intracellular ATP levels are decreased
4-fold in HeLa 0 cells and 16-fold in MDAMB435 0
cells (Table 1), confirming that the intracellular level of
ATP is reduced in cells with dysfunctional mitochondria
as expected.
3.2. Mitochondrial dysfunction causes imbalanced
dNTP pools
We have previously shown that mitochondrial dys-
function causes genomic instability that is due to TLS
[15]. Genomic instability involving TLS has been sug-
gested to be caused by imbalanced nucleotide pools
[20,21] and therefore, we investigated if the cellular
dNTP pools are affected by mitochondrial dysfunction.
Using a polymerase extension assay, we measured dNTP
pools in two different human 0 cell lines and com-
pared the results to their respective parental + cell
lines. Within the cell, the dNTP content is separated into
two compartments, the cytosolic and the mitochondrial,
which provide dNTP for synthesis of the nuclear and
mitochondrial DNA, respectively. We found no differ-
ence in mitochondrial dNTP levels between 0 cell lines
and their corresponding + cell lines (data not shown).
Since the mitochondrial dNTP content only encompass
1/10 of the total dNTP pool size in proliferating + cells
(data not shown), we did not exclude the mitochon-
dria from the cytosolic fractions in our dNTP assays.
Our results show that there is a significant difference
in whole cell dNTP levels between 0 cell lines and
their corresponding + cell lines (Fig. 1A). In HeLa 0
cells the whole cell dTTP and dCTP levels are reduced
5–6 fold compared to the corresponding pools in the
parental + cell line (Tukey, n = 3; p < 0.001). We did
not find any convincing difference in dATP and dGTP
levels between HeLa + and HeLa 0 cells. In order
to exclude that reduced dNTP pools in cells with dys-rch 625 (2007) 112–124
functional mitochondria is specific for HeLa cells, we
also measured dNTP pools in MDAMB435 0 cells. The
dNTP pools were also decreased in these cells, however,
the differences were more evenly distributed between
the dTTP, dATP, dCTP and dGTP pools with a 2–3
fold decrease compared to MDAMB435 + cells (Tukey,
n = 3; p < 0.001) (Fig. 1A).
Cytosolic dNTP levels are reduced in non-
proliferating cells compared to proliferating cells due to
reduced activity of the ribonucleotide reductase (RNR)
and thymidine kinase 1 (TK1) [43]. Cells with dysfunc-
tional mitochondria grow more slowly than + cells and
cell cycle analysis showed a lower fraction of 0 cells
in S-phase compared to + cells (Fig. 2). To ensure that
the lower dNTP levels in 0 compared to + cells are not
a result of a smaller number of 0 cells in S-phase, we
normalized the dNTP levels to the number of S-phase
cells (Fig. 1B). As shown in Fig. 1B, upon normal-
ization a difference in dTTP and dCTP levels between
HeLa 0 and + cells persisted. Low levels of all four
deoxynucleotides were also found in the MDAMB435
0 cells when compared to the parental + cells. These
results exclude the difference in cell cycle distribution
between 0 and + cells as a critical factor for the lowered
dNTP levels in cells with dysfunctional mitochondria.
We investigated if the whole cell dNTP levels of 0 cell
lines could be restored to the levels of the corresponding
+ cell lines by increasing the concentration of uridine
supplement. We treated cells with up to 100 g/ml uri-
dine, but found no significant effect on the dNTP levels
of both HeLa and MDAMB435 0 and + cells (data
not shown). Our results suggest that mitochondrial dys-
function results in dNTP pool imbalance which is not
restorable with addition of uridine.
Salvage of deoxynucleosides is carried out by
deoxynucleoside kinases that catalyze transfer of the
first phosphate group from a phosphate donor, typically
ATP, to the 5′-OH group at the deoxyribose. TK1 is the
cytosolic thymidine kinase phosphorylating only thymi-
dine and deoxyuridine [44]. In order to investigate if
altered activity of TK1 could explain the low levels of
dTTP in 0 cells, we measured TK1 activity by assay-
ing the phosphorylation of [3H]-AZT. We found HeLa
+ and 0 cells to have identical TK1 activities whereas
MDAMB435 + cells have a TK1 activity twice as high
than MDAMB435 0 cells (Fig. 3). We conclude that
decreased dTTP pool in HeLa 0 cells is not caused by
altered TK1 activity due to mitochondrial dysfunction.
The decreased dNTP levels in MDAMB435 cells are not
explainable as a result of the change in TK1 activity since
all measured deoxyribonucleotides are affected and TK1
has a very restricted substrate activity.
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evels, respectively. (B) Total levels of dNTP were normalized to the
ines (n = 3; error bars indicate S.D.). The abbreviations used are: H+
.3. Dysfunctional mitochondria and nuclear DNA
epair
Imbalanced nucleotide pools are believed to affect
ntegrity of genomes and we have previously demon-
trated that cells with dysfunctional mitochondria
isplay a mutator phenotype, which is associated with
he Rev1, Rev3 and Rev7 subunits of the error-prone
epair pathway [15]. These results could indicate that
here is a higher amount of unrepaired endogenous
NA lesions in 0 cells compared to the parental +
ells. Along these lines, we also showed that human
0 cells contain increased nuclear DNA damage after
reatment with hydrogen peroxide [16]. Together thisof cells in S-phase in HeLa 0, MDAMB435 0 and parental + cell
+; H0, HeLa 0; M+, MDAMB435 +; M0, MDAMB435 0.
suggests an impairment of nuclear DNA repair activ-
ities in response to mitochondrial dysfunction in both
yeast and human cells. Therefore, we initiated studies
to clarify which of the major nuclear DNA repair activ-
ities that could be affected by defective mitochondrial
function.
First, we used the COMET assay to achieve a gen-
eral assessment of the endogenous DNA damage level
of human 0 cells. This assay is a rapid and relatively sen-
sitive method for detecting alkali labile sites as well as
single and double stranded breaks in the DNA. Alkaline
treatment causes the DNA strands to unwind allow-
ing visualization of alkali labile sites, double stranded
breaks, single stranded breaks, crosslinks and incom-
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Fig. 2. The cell cycle distribution of HeLa 0, MDAMB435 0 and parental + cell lines, was determined by flow cytometry. Panel A displays the
the staprofile obtained by staining with propidium iodide. Panel B displays
S-phase.
plete excision repair sites, resulting from endogenous
DNA damage [37]. These types of DNA damage are
generally corrected by the BER, NER and RER path-
ways. The comet assay gives a rough estimate of whether
cells with dysfunctional mitochondria contain increased
Fig. 3. Thymidine Kinase 1 activity in cells with dysfunctional mito-
chondria. Thymidine Kinase 1 (TK1) activity was assayed by its
selective ability to phosphorylate [3H]-AZT (n = 2; error bars indi-
cate S.D.). The abbreviations used are: H+, HeLa +; H0, HeLa 0;
M+, MDAMB435 +; M0, MDAMB435 0.ining of BrdU incorporated into DNA. Black dots represent cells in
endogenous nuclear DNA damage compared to wild-
type cells. We did not find any significant difference
between the HeLa 0 and MDAMB435 0 cell lines
and their parental + cell lines using the COMET assay
(data not shown). Our data do not exclude a differ-
ence in repair ability of endogenous DNA damage
between 0 and + cells; however, any potential dif-
ferences are too subtle to be measured by the COMET
assay.
HNPCC tumors and a proportion of sporadic colon
cancers are deficient in MMR activity and these
tumors display a widespread genomic instability that
is most easily recognized by examining short repeated
sequences (microsatellites). MSI is a unique form of
genomic instability and is most often observed in cells
deficient in either hMSH2 or hMLH1. Defects in MMR
lead to genomic instability characterized by expansion
or contraction of simple repeat sequences in the nuclear
DNA. In order to clarify if the mitochondrial-mediated
genomic instability is caused by defects in MMR
activity, we investigated the function of MMR in 0
cells by analyzing five microsatellite markers (two
mononucleotide repeats: BAT25 and BAT26; and three




























ig. 4. Microsatellite instability in cells with dysfunctional mitochond
gure shows selected examples from microsatellite analysis at the BA
data not shown).
inucleotide repeats: D2S123, D5S346 and D17S250)
ecommended in the National Cancer Institute (NCI)
et. We found no microsatellite instability in the
CI set of markers in HeLa 0 and MDAMB435
0 cells when compared to their parental + cells
Fig. 4). Our results suggest that nuclear MMR activity
s preserved in cells with defective mitochondrial
unction.
Thymine depletion is toxic, partly due to an increase
n the dUTP/dTTP ratio and subsequent incorporation of
UTP instead of dTTP into DNA. Uracil incorporation in
NA is mutagenic and is usually repaired by BER. The
athway is initiated by removal of the incorrect base by
uracil glycosylase to create an AP site followed by
icking of the damaged DNA strand by AP endonucle-
se upstream of the AP site allowing excision of the AP
ite. It has previously been shown that AP endonuclease
ctivity is decreased in 0 cells and that AP endonuclease
eficiency results in sensitivity to thymine deprivation
12,45,46]. Since we demonstrate a low level of the dTTP
ool in 0 cells, it is possible that the dUTP/dTTP ratio
n 0 cells is affected and that the mutator phenotype
bserved in 0 cells is caused by excess uracil incorpora-
ion in DNA. Therefore, we compared incision activities
f mitochondrial as well as nuclear extracts in + and 0I analysis of HeLa 0, MDAMB435 0 and parental + cell lines. The
D17S250 loci. All loci were assayed in triplicates and appear stable
cells on uracil DNA lesions and oxidized bases (Fig. 5).
We did not detect any significant differences in incision
activities suggesting that the DNA incision step of BER
is unaffected in 0 cells.
3.4. Chromosomal instability
Previous studies demonstrate that imbalanced dNTP
pools can lead to delay of replication fork progres-
sion, double strand breaks, and expose fragile sites
[20,22,24–28]. All these DNA lesions are potential
originators of chromosomal instability such as transloca-
tions and rearrangements. We therefore carried out SKY
analysis to investigate if dysfunctional mitochondria
and/or imbalanced dNTP pools caused CIN. SKY anal-
ysis revealed specific chromosomal changes in 0 cells.
These were translocations at t(20;9) and t(22;6) (Fig. 6).
Interestingly, database analysis of cancer chromosomes
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=
search&DB=cancerchromosomes) indicate that the
translocations identified in 0 cell lines are found
in many tumors including breast tumors [12]. Our
results suggest that mitochondrial dysfunction causes
imbalanced dNTP pools, which result in DNA damage
that promote chromosomal translocations.
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Fig. 5. Base incision capacity in cells with dysfunctional mitochondria. Capacity of (A) mitochondrial and (B) nuclear extracts from HeLa wt and
aining
ated witHeLa 0 cells, respectively, to incise oligonucleotide substrates cont
oligonucleotide with a single uracil or 5-OH-uracil residue was incub
4. Discussion
Reported intracellular concentrations of the four
dNTPs vary considerably between organisms and cell
lines. In addition, there appears to be a consensus that
the pools are not equal but can differ up to 10-fold.
Generally, the dTTP pool is highest and dGTP the low-
est pool in proliferating cells [43,47–53]. In quiescent
cells, dNTP levels are several fold lower [49], and in
non-proliferating peripheral blood lymphocytes which
are truly G0 cells, the dTTP pool is reported to be sev-
eral fold lower than the other three pools [43,47,48,54].
Thus, low dTTP pool may explain the finding of the
pronounced DNA strand-break repair promoting effect
of 1–2 M thymidine in UV-irradiated non-dividing
human lymphocytes [55]. In order to investigate the
mechanism underlying mitochondria-mediated genomica single uracil or 5-OH-uracil lesion. Ninety femtomoles of a 30-nt
h the indicated amount of extract for 1 h at 37 ◦C.
instability, we examined the relationship between mito-
chondrial dysfunction, dNTP levels, DNA repair activity,
and chromosomal stability. We show that mitochondrial
dysfunction leads to a decrease in dNTP pools as well
as genomic instability. The nature of this instability is
similar to CIN, which is one of the hallmarks of cancer
cells.
Due to the number of mitochondrial-encoded sub-
units of the ETC, the ETC of 0 cells is non-functional
resulting in a reduced ATP production. An insufficient
supply of ATP has been suggested to contribute to
the mutator phenotype observed in 0 cells by affect-
ing ATP-dependent pathways involved in transcription,
DNA replication, DNA repair and DNA recombina-
tion [56]. Several processes of dNTP synthesis are
ATP-dependent, most notably the phosphorylation of
deoxyribonucleoside mono- and diphosphates yielding
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Fig. 6. Chromosomal instability in cells with dysfunctional mitochondria. Chromosomal instability in parental + and 0 MDAMB435 breast cancer






















ells was analyzed as described in Section 2. Translocations present i
ound in 0 cells are presented in yellow columns. Minimum of 15 me
olor in this figure legend, the reader is referred to the web version of
NTP. Therefore, it is possible that the low and imbal-
nced nucleotide pools characterizing human 0 cells is
result of low ATP levels in these cells. Our results show
n expected decrease of ATP levels in both HeLa 0 and
DAMB435 0 cells compared to their parental + cell
ines. However, the correlation between the decrease of
TP levels and the decrease of dNTP levels is not iden-
ical in the two cell lines. This suggests that factors and
athways, other than ATP synthesis, are compromised
nd contribute to down regulation of dNTP synthesis.
nterestingly, we found that decreased levels of ATP did
ot result in any reduction of TK1 activity in HeLa
ells or impairment of repair of endogenous nuclear
NA damage in both cell lines, indicating that the
TP levels of 0 cells are sufficient for, at least, these
rocesses.Retrograde communication between mitochondria
nd the nucleus has been demonstrated and one sug-
ested role of this communication is to provide a link
etween mitochondrial status and cell cycle regulationell lines are presented in gray column whereas specific translocation
s were analyzed in each case. (For interpretation of the references to
cle.)
[13,56,57]. When damage to mitochondria is persistent,
it has been suggested that the retrograde communica-
tion becomes irregular and has an unfavorable effect
on the cell [56]. In human breast cancer 0 cells,
the retrograde communication between the mitochon-
dria and the nucleus has been suggested to result in
altered expression of nuclear genes involved in signal-
ing, cellular architecture, metabolism, cell growth, and
apoptosis [33]. Using S. cerevisae as a model system,
it has been shown that mitochondrial dysfunction leads
to altered expression of a group of genes [56], which
could explain the imbalanced dNTP levels of 0 cells
(data not shown). These genes include CDC21 express-
ing thymidylate synthase that has an essential role in
the de novo synthesis of dTTP by mediating the methy-
lation of dUMP yielding dTMP. Human thymidylate
synthase is encoded by TYMS and several chemother-
apeutic agents that target thymidylate synthase are used
for treatment of tumors [58,59]. The effect of these
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inhibit the formation of dTTP resulting in stagnation
of cell growth. When mouse FM3A cells were treated
with the chemotherapeutic agent 5-flourodeoxyuridine
(5-FU), the thymidylate synthase was inhibited and an
imbalance of the dNTP pools was observed. The lev-
els of dTTP and dGTP were strongly reduced, while
the dATP pool was increased [59]. Furthermore, it
has been shown that Inosine 5′-monophosphate dehy-
drogenase type 2 (IMPDH2) involved in nucleotide
biosynthesis was upregulated in 0 cells. IMPDH2 is
a rate-limiting enzyme in de novo guanine biosynthesis
[13].
In this study, we show that mitochondrial dysfunction
does not result in a substantial reduction in overall repair
activities when measured as the ability to repair endoge-
nous damage of the nuclear DNA. Remarkably, we show
that the first step in BER, the incision of DNA dam-
age, is unaffected in 0 cells whereas it has previously
been shown that the downstream AP-endonuclease in
BER is down-regulated in 0 cells [12,45]. The result of
such deregulation of BER activities could result in excess
of mutagenic AP-sites that can be converted into muta-
tions by the TLS pathway [60]. Our results also show
that proliferating 0 cells contain imbalanced dNTP
pools compared to parental cell lines. Concurrently mito-
chondrial dysfunction is demonstrated to contribute to
chromosomal translocations and rearrangements. The
nature of the genomic instability observed in human 0
cells is similar to that of the CIN pathway. This particular
form of genomic instability is characterized by muta-
tions in cell-cycle regulators, checkpoint proteins, and
structural components of the mitotic spindle [31]. Thus,
our results suggest that mitochondrial function is funda-
mental for maintaining genomic integrity by preventing
chromosomal translocations and rearrangements, which
are associated with a variety of human diseases such as
cancer.
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in  a  higher  mutation  frequency,  the  increase  is  also  essential  for  cell  survival 
following  treatment  with  DNA  damaging  agents.  Increased  levels  of  dNTP  are 
believed to facilitate DNA translesion synthesis (TLS) at the expense of induced 
mutations. We propose that different TLS polymerases have their highest activity 
at  different  dNTP  concentrations,  and  that  the  dNTP  levels  therefore  not  only 
facilitate TLS but also regulate the TLS response. 
By  treating  several  strains  with  the  alkylating  agent methyl‐methanesulfonate 
(MMS), we have shown that dNTP levels increases in logarithmic phase cells in a 
time‐dependent  manner.  We  have  demonstrated  that  after  1  hour  of  MMS 
treatment,  strains  displayed  an  increase  of  dNTP  levels  but  no  increase  in 
mutation  frequencies.  After  2.5  hours  of  MMS  treatment  strains  displayed  a 
further  increase  in  dNTP  levels  and  an  increase  of  mutation  frequencies. 
According to our hypothesis, moderate increased levels of dNTP mediate error‐
free  TLS,  while  further  increase  mediates  error‐prone  TLS  in  response  to  the 
DNA damaging agent.  
A  deletion  of  REV3,  encoding  the  catalytic  subunit  of  the  error‐prone  TLS 
polymerase ζ, was  shown not  to  induce mutation  frequency  after  2.5  hours  of 
MMS  treatment  indicating  the  involvement  of  the  error‐prone  polymerase  and 
substantiating our hypothesis. 
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supply  of  deoxyribonucleotides  triphosphate  (dNTP)  can  cause  genomic 
instability [Reichard 1988]. Consequently, the cellular dNTP pools are subject to 
stringent  regulation.  In Saccharomyces  cerevisiae, DNA  lesions  that  inhibit DNA 
replication, have been reported to result in a 6 to 8 fold increase in dNTP levels. 
This  increase  is  responsible  for  an  increased mutation  frequency  but  has  also 
been  demonstrated  to  be  essential  for  cell  survival  following  DNA  damage 
[Chabes et al.,  2003; Lis et al.,  2008]. In mammals, dNTP can be synthesized by 
both  salvage  and  de  novo  pathways.  Excess  dNTPs  are  degraded  by 
deoxyribonucleotidases where  after  the  resulting  deoxyribonucleosides  can  be 
excreted  from  the  cell  [Reichard  1988;  Bianchi  and  Spychala  2003].  Unlike 
mammalian  cells,  yeast  cells  are  not  able  to  synthesize  dNTP  by  the  salvage 
pathway,  and  no  excretion  of  deoxyribonucleosides  has  been  documented  in 
yeast [Reichard 1988; Chabes and Stillman 2007]. This focuses the regulation of 
dNTP  levels  in  yeast  at  the  rate‐limiting  step  of  the  de  novo  pathway;  the 
reduction  of  ribonucleotides  to  2’‐deoxyribonucleotides  catalyzed  by 
ribonucleotide  reductase  (RNR)  [Larsson  and  Reichard  1966].  The  enzymatic 
activity  of  RNR  is  controlled  by  several  regulatory  mechanisms,  including 
allosteric  regulation  [Kaslan  et  al., 2002],  transcriptional  regulation  or 
posttranscriptional  inhibitors  controlled  according  to  cell  cycle  or  induced  by 
DNA  damage.  After  DNA  damage  RNR  is  transcriptionally  induced  via  the 




et  al., 1998].  The  correlation  between  increased  dNTP  levels  and  cell  survival 
following DNA  damage  has  been  proposed  to  be  the  result  of  a more  efficient 
DNA  translesion  synthesis  (TLS)  following  the  elevated  dNTP  concentrations 
[Chabes et al., 2003]. Progression of the replicative DNA polymerase is stalled by 
encountering  a  variety  of  DNA  lesions,  increasing  the  risk  of  a  double  strand 
break  [Friedberg  and Gerlach 1999]. During TLS,  the  replicative polymerase  is 
displaced by one or more translesion polymerases allowing bypass of the specific 
DNA  lesions  that  inhibit  replication  fork  progression.  The  bypass  of  DNA 
damages can be either error‐free or error‐prone, depending on the nature of the 
DNA  damage  as  well  as  the  TLS  polymerase  [Hübscher  et  al., 2000].  TLS  is 
usually mediated by one polymerase but certain DNA lesions require the action 
of  two different  polymerases: One mediating  the  nucleotide  insertion  opposite 
the lesion site and one performing the subsequent extension reaction [Prakash et 
al., 2005].  In  yeast,  several  polymerases  are  available  for  TLS,  including 
polymerase  ζ,  η  and  the  replicative  polymerase  δ.  The  constellation  of  DNA 




dNTP  levels were  demonstrated  to  be  essential  for  the  TLS mediated  survival 
following DNA damage. On this background, we hypothesize that the purpose of 




concentrations  [Chabes et al., 2003], hence, by  increasing  the dNTP  levels until 




The  laboratory  of  our  collaborator  Dr.  Workman  (Technical  University  of 
Denmark)  has  recently  mapped  the  transcriptional  network  controlling  the 
damage  response  in  yeast  after  treatment  with  the  alkylating  agent  methyl‐
methanesulfonate  (MMS)  [Workman  et  al., 2006].  Using  this  transcriptional 
network  we  have  selected  candidate  genes  that  may  be  responsible  for  the 
increase  of  dNTP  levels  in  response  to  DNA  damage  (See  table  1;  Figure  1). 









Dun1  Cell‐cycle  checkpoint  serine‐threonine  kinase  required  for  DNA  damage‐induced 






Tup1p  and  Cyc8p  to  their  promoters;  involved  in  DNA  damage  and  replication 
checkpoint pathway; similar to a family of mammalian DNA binding Rfx1‐4 proteins 
Mbp1  Transcription  factor  involved  in  regulation  of  cell  cycle  progression  from  G1  to  S 














Yeast  cells  were  grown  in  YPD  medium  (Clontech,  Medinova  Scientific  A/S, 
Denmark).  Cells  were  plated  on  YPD  agar  plates  or  SD/‐Arg  +  60  µg/ml 
canavanine plates (Clontech, Medinova Scientific A/S, Denmark). 
S.  cerevisiae  strains  used  are  listed  in  table  2  and  were  obtained  from  the 





















number  of  canavanine  resistant  colonies  counted.  Appropriate  dilutions  of  the 
same cultures were plated on YPD plates to determine the number of viable cells. 
For  each  set  of  experiments  five  independent  cultures  of  each  strain  were 
assayed,  and  each  experiment  was  repeated  at  least  3  times.  All  data  are 






yeast  cells were pelleted  and  resuspended  in 1ml 60% methanol  solution. The 
cells  were  disrupted  by  10  consecutive  freeze  and  thaw  cycles  using  liquid 
nitrogen  and  warm  water  and  the  suspension  was  incubated  at  ‐20°C  for  90 
minutes,  and  boiled  at  100°C  for  3  minutes  in  order  to  remove  remaining 
enzyme activity. The lysate was centrifuged at 17000×g for 15 minutes and the 
supernatant  frozen  in  liquid  nitrogen.  Methanol  was  evaporated  using  a 
SpeedVac  (Thermo  Scientific)  and  the  residue was  rehydrated  in  300 µl Ultra‐
  10 
pure H2O (Invitrogen, GIBCO). Determination of cellular dNTP concentration was 
performed  as  earlier  described  [Desler  et  al., 2007].  Each  experiment  was 
repeated at least 3 times 
 
Determination  of  mutation  frequencies  and  dNTP  levels  after  treatment  with 
MMS 
Overnight  cultures  in  stationary phase, were  grown  in YPD media  at  30oC  and 
mutation  frequency  and  dNTP  levels were  determined  as  described,  for  either 
untreated cells or cells treated with a supplement of 0.025% MMS for 1 hour at 
30oC. 
For  logarithmic  phase  cells,  overnight  cultures were  diluted  1:50  in  YPD  for  3 
hours at 30oC  to  ensure  that  cells were  in  logarithmic phase. Cells were either 
assayed directly for mutation frequencies and dNTP content as described above, 
or  following growth  in the presence of 0.025% MMS for 1 or 2.5 hours. During 











To  determine  if  DNA  lesions  cause  an  alteration  of  dNTP  levels  in  stationary 
phase  cells,  wild  type  strain,  as  well  as  RAD9,  MBP1,  RFX1,  DUN1  and  RNR3 
deletion  strains  was  treated  with  0.025%  MMS  for  1  hour  where  after  the 
frequency  of  mutation  in  the  CAN1  gene  was  determined  and  dNTP  levels 
measured. With the exception of the DUN1 deletion mutant, a significant 2 to 5‐
fold  increase  in mutation  frequency was demonstrated  for  the different strains 






to 5  fold  increase  in mutation  frequency after MMS  treatment  (n=3 error‐bars  indicate S.D.  (*) 









MMS  treatment where  all  investigated  strains, with  the  exception  of  the RAD9 
deletion strain, displayed significant  increased dGTP  levels and all  investigated 
strains, with  the exception of wild  type and the RAD9 deletion strain displayed 
significant  increased dCTP  levels  in  response  to MMS  treatment.  For  the dTTP 
pool,  only  wild  type,  the  RFX1  and  the  RNR3  deletion  strains  displayed  a 
significant  increase  in  response  to  MMS  treatment.  For  the  dATP  pool,  no 










hour with  or without  0.025% MMS.  From  top  left  to  bottom  right  are  shown  the  dTTP,  dATP, 
dCTP  and  dGTP  levels,  respectively.  (n=3  error‐bars  indicate  S.D.  (*)  Denotes  significant 
difference. The  statistical  analysis was performed using Student  t‐test. A difference at p < 0.05 
was considered significant.) 
 
Treatment  with  MMS  for  1  hour  causes  increased  dNTP  levels  but  do  not 
increase mutation frequency in cells in logarithmic phase  
To  investigate possible  link between treatment with DNA damaging agents and 
dNTP pools  in  logarithmic phase cells, wild  type strain as well  as RAD9, MBP1, 
RFX1,  DUN1  and  RNR3  deletion  strains  were  treated  with  0.025% MMS  for  1 
hour during logarithmic growth and assayed for dNTP content (Figure 4). With 
exceptions, all investigated strains displayed a significant increase in dTTP, dCTP 




where  no  significant  difference  was  measured  between  untreated  and  cells 
treated with MMS. As was the case for stationary phase cells treated with MMS, 
the dATP pool of  logarithmic phase cells was not as affected as the dTTP, dCTP 
and  dGTP  pools  by  the MMS  treatment  and  only  the RAD9  and DUN1  deletion 
strain displayed a significant increase of dATP levels of a magnitude of 10‐14 fold 
in response to MMS treatment.  















for  1  hour with  or  without  0.025% MMS.  From  top  left  to  bottom  right  are  shown  the  dTTP, 
dATP, dCTP and dGTP levels, respectively. A 5‐30 fold increase of the dNTP levels of MMS treated 
strains was  demonstrated  in  response  to MMS  treatment. With  exception  of  the  dTTP  pool  of 
RAD9  and  the  dGTP  pool  of  the DUN1  deletion  strain,  no  significant  difference  exist  between 
treated wild type strain and deletion strains (n=3 error‐bars indicate S.D. (*) Denotes significant 


























Figure 6. Nucleotide pools  in wild  type and deletion strains  in  logarithmic phase, untreated or 
treated for 1 or 2.5 hours with 0.025% MMS. From top left to bottom right are shown the dTTP, 






During  the  course  of  the  2.5  hour  of MMS  treatment,  especially  the wild  type 
strain  displayed  a  dramatic  increase  of  dNTP  levels,  where  treated  cells 
contained 20‐60 fold higher concentrations of the four dNTP when compared to 
untreated cells.  
For  the RFX1  and  SML1  deletion  strains,  the  concentrations  of  dNTP  after  2.5 
hours of MMS treatment is comparable to the dNTP concentration for wild type 







  dTTP  dATP  dCTP  dGTP 
0 hour  1  2.4  1.6  1.9 
1 hour  1  0.8  0.8  0.9 
2.5 hours  1  0.9  0.9  1.0 
Table 3.  The  ratio  of  dTTP/dATP/dCTP/dGTP pools  of wild  type  strains  in  logarithmic phase, 




The  mutation  frequencies  of  logarithmic  growing  wild  type,  RFX1,  SML1  and 
REV3 deletion strains was determined for untreated cells and cells treated with 
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MMS  for  2.5  hours  (Figure  7). Wild  type, RFX1  and  SML1  deletion  strains was 
measured to have a 5 to 6 fold increase in mutation frequencies when comparing 
to untreated cells. This is in contrast to investigated strains treated with MMS for 
1  hour,  where  no  significant  difference  were  measured  when  compared  to 
untreated cells. This  indicated that the capabilities of  these cells  to repair MMS 
induced lesions had been saturated after 2.5 hours of treatment. In contrast, only 
a  3  fold  increase  of  mutation  frequencies  were  measured  between  untreated 
REV3  deletion  strains  and REV3  deletion  strains  treated with 0.025% MMS  for 















In stationary cells, same treatment only  induces an up to 2  fold  increase of  the 
dNTP pool. This indicates that treatment with MMS is followed by an increase of 











dependent  increase  of  dNTP was  demonstrated  for  all  strains  investigated.  In 
wild  type  strain,  the  dNTP  content  increased  20‐60  fold  during  2.5  hours  of 
treatment.  Interestingly,  MMS  treatment  does  not  only  induce  an  increase  in 





in  mutations  by  its  own.  To  verify  this  finding  it  is  important  to  perform 
additional measurements  in  order  to  have  sufficient material  to make  a more 
precise statistical analysis of the ratio differences.  
The  differences  in  dNTP  levels  reported  in  this  paper  are  much  higher  than 
reported in other works [Chabes et al., 2003; Lis et al., 2008]. These differences 
are most likely due to the fact that two different approaches have been utilized in 
the  determination  of  dNTP  levels.  In  this  paper  we  have  utilized  the  Klenow 





are  9‐16  fold  higher  than  corresponding  dNTP  levels  of  wild  type  strains.  In 
contrast  the  dNTP  levels  of RFX1  deletion  strains  are  only  2  fold  higher.  Even 
though  untreated  RFX1  and  SML1  deletion  strains  have  an  increased  dNTP 
concentration compared to the wild type strain, the two RNR inhibitor knock‐out 






In  spite  of  treatment  with  MMS  for  1  hour  and  a  resulting  increase  in  the 
concentration of dNTP levels, logarithmic phase cells do not present a significant 
increase  in mutation frequency when compared to untreated cells.  It  is evident 
that  these  strains  are  able  to  tolerate  the  DNA  lesions  induced  by  MMS  and 
altered levels of dNTP. An explanation would be that the increased dNTP levels 
facilitates DNA repair or damage by‐pass  in an error‐free  fashion, but  to prove 
that the increase in dNTP concentration is necessary for this tolerance, we would 
have required a strain which did not induce the dNTP levels in response to MMS 
treatment.  By  using  this  strain  it would  be  possible  to  investigate  if  1  hour  of 




the  REV3  deletion  strain,  displayed  an  increase  in  mutation  frequencies. 
According  to  our  hypothesis,  different  TLS  polymerases  have  their  highest 
activity at different dNTP concentrations and  the dNTP  levels will  regulate  the 
TLS  response.  If  the  signal  for  increased  dNTP  levels  is mediated  by  a  stalled 
replication fork,  the dNTP levels would continue to  increase until a suiting TLS 
response was  found  for bypass of  the DNA  lesion whereby  the  replication  fork 
could  be  continue  its  progression.  In  the  progression  of  TLS  response  to MMS 
damage,  a  moderate  increase  in  dNTP  levels  after  1  hour  of  MMS  treatment 
appears to have activated error‐free TLS, while the further increased dNTP levels 
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after  2.5  hours  of  MMS  treatment  utilizes  error‐prone  TLS  in  response  to  the 
treatment (Figure 8). 
 
Figure 8. Model of  the hypothesized relationship between dNTP  levels,  following DNA damage 
inducing  agents,  and  the  TLS  response.  According  to  the model,  a moderate  increase  of  dNTP 




3‐fold  increase  in  mutation  frequency.  This  indicates  either  that  the  REV3 
deletion strain had not saturated its ability to perform error‐free repair or DNA 
lesion bypass after 2.5 hours of MMS treatment or that the cells where unable to 
initiate  error‐prone  repair  or DNA  lesion bypass  once  the  error‐free pathways 
was saturated, leading to a decreased survival rate of the culture. REV3 encodes 
the  catalytic  subunit  of  the  error‐prone  TLS  polymerase  ζ  [Sakamoto  et  al., 
2007], and it is therefore highly probable that the mutation response seen in the 
other strains was mediated by this part of the TLS pathway.  
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The definition of a hypothetical protein is a protein that is predicted to be expressed 
from an open reading frame, but for which there is no experimental evidence of 
translation. Hypothetical proteins constitute a substantial fraction of proteomes of 
human as well as other eukaryotes. With the general belief that the majority of 
hypothetical proteins are the product of pseudogenes, it is essential to have a tool with 
the ability of pinpointing the minority of hypothetical proteins with a high probability 
of being expressed. 
Results 
Here, we present an in silico selection strategy where eukaryotic hypothetical proteins 
are sorted according to two criteria that can be reliably identified in silico: the 
presence of subcellular targeting signals and presence of characterized protein 
domains. To validate the selection strategy we applied it on a database of human 
hypothetical proteins dating to 2006 and compared the proteins predicted to be 
expressed by our selecting strategy, with their status in 2008. For the comparison we 
focused on mitochondrial proteins, since considerable amounts of research have 
focused on this field in between 2006 and 2008. Therefore, many proteins, defined as 
hypothetical in 2006, have therefore later been characterized as mitochondrial.  
Conclusions 
Among the total amount of proteins hypothetical in 2006, 21% have later been 
experimentally characterized and 6% of those have been shown to have a role in a 
mitochondrial context. In contrast, among the chosen hypothetical proteins from the 
2006 dataset, predicted by our strategy to have a mitochondrial role, 53-62% have 
later been experimentally characterized, and 85% of these have actually been assigned 
a role in mitochondria by 2008. 
 
Therefore our in silico selection strategy can be used to select the most promising 
candidates for subsequent in vitro and in vivo analyses. 
 
Background 
According to the Human Genome Organization (HUGO), the human genome is 
predicted to consist of 19599 protein-encoding genes [1, Human Genome Project 
(http://www.hugo-international.org/)]. A substantial part of these genes is predicted to 
encode a group of proteins, where translation has not been demonstrated and the 
proteins themselves have not been characterized. This group of proteins is 
accordingly defined as hypothetical. Although many of the listed hypothetical 
proteins most likely are predicted products of pseudogenes, there is a reasonable 
probability that a number of the listed hypothetical proteins are truly novel and can 
perform uncharacterized biological functions. Consequently, the putative importance 
of hypothetical proteins is not negligible. 
 
Several in silico methods are available for descriptive predictions of proteins with 
unknown function. These include studies of homology, database searches for 
orthologs, or the presence of characterized functional domains or motifs within the 
protein [2]. Most often false positives will occur and predictions must be substantiated 
by in vitro and/or in vivo experiments to validate and further characterize predicted 
functionality. The in silico methods are designed for functional prediction of a 
protein, but not specifically designed to ascertain whether a protein is hypothetical or 
not. When screening hypothetical proteins for novel translatable candidates in silico 
methods are therefore rarely used and the researcher often performs the screen with 
laborious in vitro and/or in vivo experiments. 
 
In the present study, we propose an in silico screening strategy for eukaryotic 
systems, in which novel translatable candidates can be selected from a group of 
hypothetical proteins. The strategy is based on in silico methods normally used to 
make functional predictions of proteins, which include search for presence of sub-
cellular targeting signals and for presence of characterized protein domains. 
Especially targeting signals and, to a lesser extent, protein domains can be predicted 
with high probability. The occurrence of either targeting signals or identifiable protein 
domains can also be present in pseudogenes as a result of gene duplication. However, 
we hypothesize that the risk of a hypothetical protein being a pseudogene is greatly 
reduced when both targeting signals and protein domains are identified in the 
transcript, especially if the protein domain architecture suggests a relevant function in 
the predicted sub-cellular compartment. Selection of hypothetical proteins based on a 
combination of both these factors should therefore greatly increase the success rate of 
discovering true functional proteins with roles in subcellular compartments among 
hypothetical proteins. Due to the design of the selection strategy it is ineffective for 
identifying proteins without localization signals, and this must be taken into 
consideration. 
 
To exemplify our selection strategy we have chosen mitochondria as the targeted sub-
cellular compartment. Within recent years, a substantial amount of work has been 
invested in compiling a near complete list of mitochondrial proteins in humans. This 
has resulted in the establishment of the MitoCarta database 
(http://www.broad.mit.edu/pubs/MitoCarta/) [3]. The total number of genes encoding 
mitochondrial proteins is according to MitoCarta at least 1013 [3]. Mitochondria are 
semiautonomous organelles present in almost all eukaryotic cells ranging from a 
single copy to several thousands. Mitochondria contain their own autonomous 
genome, which encodes 37 of these proteins. The reminder is encoded by nuclear 
DNA and imported into mitochondria. Examples of mitochondrial functions include 
ATP production by oxidative phosphorylation, β-oxidation of fatty acids, metabolism 
of amino acids and of lipids. Furthermore, mitochondria have a prominent role in 
apoptosis.  
 
With the exception of proteins encoded by the mitochondrial genome, proteins are 
translated in the cytosol from their corresponding mRNA. Many proteins are 
transported to specific parts of the cell where they function in context of the sub-
cellular compartment. The sub-cellular localization of proteins can be facilitated by 
specific targeting peptides. There are two types of targeting peptides, the 
presequences and internal targeting signals. Presequences are often localized at the N-
terminal whereas internal targeting signals can be distributed throughout the protein 
sequence [4-6]. The mitochondrial membrane contains translocases for recognition 
and import of nuclear-encoded mitochondrial proteins. The translocase of the outer 
mitochondrial membrane (TOM complex) is responsible for recognition and initial 
import of nuclear-encoded mitochondrial proteins (reviewed in [7]). Mitochondrial 
precursor proteins posses either an N-terminal presequence or internal targeting 
signals. Both types of targeting peptides, N-terminal or internal, are recognized by 
different import receptors of the TOM complex. N-terminal presequences generally 
have a length of 6-85 amino acid residues, enriched in Arg, Ser and Ala, while 
negatively charged amino acids are rarely present [8]. N-terminal presequences form 
positively charged amphiphilic α-helices when bound to import receptors on the 
mitochondrial surface [9], and upon mitochondrial import, presequences are removed 
by proteolysis (reviewed in [10,11]). Even though binding of different parts of the 
TOM complex to varying internal targeting signals has been shown [12], a common 
motif for an internal targeting signal has still to be elucidated,  
 
In order to validate that our in silico selection strategy can predict functional 
candidates among hypothetical proteins we chose to focus on proteins with a 
predicted mitochondrial function. We have utilized an existing database of 
hypothetical proteins assembled in 2006 [13]. From this database we selected all 
hypothetical proteins predicted to be localized in human mitochondria due to the 
presence of a suspected mitochondrial N-terminal presequence. These selected 
proteins were then investigated for the presence of potentially functional protein 
domains. We predict that the sub-group of hypothetical proteins, with both a 
mitochondrial N-terminal presequence and potentially functional protein domains has 
a high probability of being expressed and having a function in a mitochondrial 
context.  
 
All proteins investigated were hypothetical in 2006. However, between 2006 and 
2008, many proteins have been experimentally characterized or removed from the 
database as they have been predicted to be products of pseudogenes. This increases 
the probability that the 2006 dataset of hypothetical proteins includes a large number 
of proteins that are now (as of 2008) classified as mitochondrial. By applying the 
selection strategy on the 2006 dataset, we are able to compare the resulting 
predictions with the factual in vitro and/or in vivo characterizations of the proteins 
performed from 2006 to 2008. Effectiveness of selection strategy can be demonstrated 
by comparing proteins selected from the 2006 dataset with the number of these 
proteins that, as of November 2008, are demonstrated to be translated, mitochondrial 




We have utilized a database of proteins extracted from GenBank in August 2006. At 
the time of extraction, all proteins were defined as hypothetical and all sequences 
were crosschecked and annotated [13]. In November 2008, the status of each 
individual protein was reinvestigated and entries of the 2006 database that later have 
been identified as duplicates were removed. The entries of the 2006 dataset were 
divided into three groups according to their individual status in November 2008: 
Hypothetical proteins, characterized proteins and proteins discovered to be 
pseudogenes and therefore are removed by GenBank. These three groups are in the 
following collectively referred to as the 2008 dataset. 
 
Several prediction programs have been designed to predict the localization of 
eukaryotic proteins. In table 2, we have listed a selection of available programs, 
which have been reported to have a medium to high prediction accuracy. To 
exemplify the occurrence of hypothetical proteins with functional targeting peptides, 
hypothetical proteins from the 2006 dataset were analyzed using pTarget. The pTarget 
program [http://bioapps.rit.albany.edu/pTARGET/] predicts protein targeting to nine 
different sub-cellular locations including mitochondria. Prediction is based on the 
occurrence of specific Pfam domains earlier determined to be location specific. 
pTarget, can predict 68-87% of the true positives at accuracy rates of 96-99% [19,20]. 
Since the program makes its predictions based on putative location-specific Pfam 
domains, and not necessarily targeting peptides verified in experimental setups, we 
have chosen to use the program only to illustrate how hypothetical proteins can be 
sorted by predicted localization. 
 
In contrast to pTarget, the TargetP program [http://www.cbs.dtu.dk/services/TargetP/] 
predicts mitochondrial localization using the N-terminal sequence information only, 
with a success rate of predictions of 90% [21]. TargetP was used to screen the 2006 
dataset for functional mitochondrial targeting peptides.  
 
All hypothetical proteins predicted to have a mitochondrial targeting peptide by 
TargetP, were further characterized using the SMART program [http://smart.embl-
heidelberg.de/]. The SMART program identifies protein domains from a database of 
manually annotated known protein domains, locating proteins with identical domain 
architecture [22, 23].  
 
We hypothesize that hypothetical proteins, predicted to contain both a mitochondrial 
N-terminal presequence and functional protein domains have a high probability of 
being functional in a mitochondrial context. To verify our hypothesis, we used the 
2006 dataset of the, then, hypothetical proteins. Using TargetP, we selected proteins 
having a high probability of containing a mitochondrial N-terminal presequence. For 
the resulting subset of proteins we used SMART to search for the presence of 
functional protein domains. Comparing with protein status according to the 2008 
dataset, we determined the percentage of selected proteins that had either been 
removed or experimentally characterized after 2006. Furthermore, if proteins had 
been experimentally characterized, we determined if they had been found to be 
functional in a mitochondrial context. 
 
Results and discussion 
After removing proteins found or predicted to be duplicates of already existing 
proteins, the 2006 dataset of hypothetical proteins contains 5860 proteins. According 
to GenBanks current annotation (November 2008) of the same group of proteins, 
1455 of the 5860 proteins annotated as hypothetical in 2006, are still hypothetical, 
while 1215 proteins have been experimentally characterized and 3190 proteins have 
been removed by GenBank as they have been identified as pseudogenes (See 
Additional file 1). 
 
pTarget was used to predict the distribution of human hypothetical proteins from the 
2006 dataset and 2008 dataset (Table 1). A third of the hypothetical proteins from 
both datasets were predicted to be nuclear, while only 2-3% were predicted to be 
localized to the endoplasmic reticulum, and 5% of investigated hypothetical proteins 
were predicted mitochondrial. We only use pTarget to exemplify how human 
hypothetical proteins can be sorted based on their predicted cellular localization. This 
is important since our selection strategy is limited to proteins targeted for a sub-
cellular localization. Using pTarget as an indicator only, we are able to demonstrate 
that proteins predicted to be localized to lysosomes, golgi, peroxysomes, 
mitochondria or endoplasmic reticulum, consists of 32% of the 2006 dataset. When 
including proteins predicted to be secreted, proteins targeted for the plasma 
membrane or nucleus, this includes 87% of the 2006 dataset. This indicates that the 
selection strategy, according to pTarget, can be applied on up to 87% of the dataset.  
pTarget is not an optimal tool for investigating hypothetical proteins. pTarget screens 
for putative Pfam domains that are related to a specific cellular localization but not 
necessarily for complete targeting signals. If a hypothetical protein turns out to be a 
pseudogene, it will most likely consist of gene duplications. Even though several 
Pfam domains related to specific cellular locations are found in a protein, the 
complete targeting signal is not guaranteed to be complete and functional. 
 
TargetP predicts probability of mitochondrial localization based solely on 
mitochondrial specific presequences. These motifs do not necessarily require cis or 
trans acting domains in order to be fully functional mitochondrial targeting signals. 
Accordingly, if a hypothetical protein is predicted to be localized to the mitochondria, 
there is a reasonable probability that a corresponding expressed protein would be 
localized to this organelle even though it may still be the product of a pseudogene. 
Screening the 2006 dataset of human hypothetical proteins with TargetP we found a 
total of 1139 proteins predicted to be localized to mitochondria (See Additional file 
1). TargetP places all of the predicted proteins into reliability classes, ranging from 1 
to 5, where 1 indicates the strongest prediction [21]. We have focused on the total of 
538 proteins belonging to reliability class 1 (52 proteins), 2 (204 proteins) and 3 (282 
proteins) (See Additional file 1).  
 
From reliability class I to III, 315 of 538 proteins (59%) selected by TargetP, had 
been removed, while 75 of 538 proteins (14%) had been characterized and 32 of 538 
proteins (6%) had been characterized as mitochondrial. When focusing on proteins 
predicted by TargetP to be in reliability class I, 15 of 52 proteins (29%) had been 
removed, 18 of 52 proteins (35%) had been characterized and 14 of 52 proteins (27%) 
had been characterized as mitochondrial (See Additional file 1). From the 2006 
dataset of hypothetical proteins, 67 are listed in MitoCarta as characterized 
mitochondrial proteins (See Additional file 1). TargetP was successful in identifying 
32 of the total of 67 mitochondrial proteins, but did also select 315 proteins that after 
2006 have been removed. When focusing on proteins belonging to reliability class I, 
14 of 67 mitochondrial proteins were identified, while 15 proteins had been removed. 
This demonstrates that TargetP is efficient in finding mitochondrial proteins, but it is 
not suitable for screening hypothetical proteins for novel translatable candidates. To 
be able to annotate the selected hypothetical proteins we screened proteins from 
reliability class I to III with the SMART program to determine the presence of known 
protein domains. We ignored proteins only containing transmembrane domains, 
coiled coil regions, signal peptides and/or segments of low compositional complexity, 
as these regions are not unique protein domains.  
 
Three groups of proteins where constructed from the 538 proteins investigated. Group 
I consists of 20 proteins, predicted by TargetP to belong to reliability class 1 and to 
contain identifiable protein domains according to SMART prediction. Group II 
consists of 56 proteins, predicted by TargetP to belong to reliability class 1 and 2 and 
to contain identifiable protein domains. Group III contains 100 proteins that are 
predicted by TargetP to belong to reliability class 1, 2 and 3 and to contain 
identifiable protein domains. Group III therefore contains all proteins of group I + II 
and group II contains all proteins of group I. The construction of these three groups 
allows us to comment on how reliable the prediction of cellular localization should be 
in order to get a good result from our selection strategy. 
 
The three groups of selected proteins were, together with the 5860 hypothetical 
proteins from the 2006 dataset, compared with their corresponding 2008 annotations. 
The comparison include localization of experimentally characterized proteins and 
proteins removed due to being the predicted result of pseudogenes or similarity to an 
existing protein (Table 3). 
 
25% of the 5860 proteins were in November 2008 still annotated as hypothetical, 21% 
had been experimentally characterized and 54% were removed. Of the experimentally 
characterized proteins, 67 proteins or 6% were listed in MitoCarta as mitochondrial. 
Group III, contains 100 proteins, where 36% in November 2008, were still 
hypothetical, 53% had been characterized and 11% had been removed. Of the 
characterized proteins 45% or 24 proteins were listed in MitoCarta as mitochondrial. 
The values obtained clearly demonstrate, that our strategy using a selection based 
both on the presence of a mitochondrial presequence and identifiable protein domains 
is very efficient for extracting hypothetical proteins with a functional role in  
mitochondria. Applying the selection strategy on the 2006 dataset identified 24 of 67 
proteins that later have been categorized as mitochondrial. Furthermore the 
percentage of removed proteins is 5-fold lower for group III when compared with the 
2006 dataset and the percentage of characterized proteins is concurrently 2.5 fold 
higher. When investigating group II and group I proteins, selected by our strategy it is 
evident that the percentage of removed proteins is diminished to 9% and 5% 
respectively, and the percentage of characterized proteins is increased to 65% and 
64% respectively. The prevalence of mitochondrial proteins within the number of 
characterized proteins increases from 6% for the total 2006 dataset to 45%, 58% and 
85% for group III, group II and group I respectively.  
 
When increasing the selectivity of the applied prediction models, in our case by 
focusing on group II and especially group I proteins, it is evident that the probability 
of finding hypothetical proteins, which will have a function in the predicted sub-
cellular compartment is increased. However, it is also evident that the higher the 
selectivity, the lower the total number of identified proteins with the desired 
functionality. For group III proteins, 24 out of a total of 67 mitochondrial proteins 
were discovered. For group I, only 11 proteins out of the 67 mitochondrial proteins 
were discovered. 
 
The three groups of investigated proteins contain a total of 36 proteins that in 
November 2008 was still annotated as hypothetical. According to our selecting 
strategy, these proteins are predicted to be expressed and to have roles in a 
mitochondrial context. To investigate the potential of these proteins, we investigated 
the protein domains of 6 hypothetical proteins of group I to see if they would suggest 
a mitochondrial function for the relevant protein (Table 4). 4 out of the 6 proteins 
each contain one domain that are experimentally characterized in mitochondria and 
therefore may have putative mitochondrial functions.  The four domains were found 
to be a Complex I- Lyr domain, a Methyltransferase 12 domain, a Sel 1 domain and a 
DUF1640 domain. The Complex I-LYR domain is present in a family of proteins 
including the mitochondrial NADH-ubiquinone oxidoreductase complex I. 
Methyltransferase 12 domain is found in a variety of methyltransferases including one 
functioning in mitochondria.  Sel I like repeats domain is found in a vast amount of 
proteins including HSP70, HSP90, and in mitochondrial Tom 70 import receptor. 
DUF1640 domain is present in the mitochondrial protein FMP32 found in 
Saccharomyces cerevisiae. [24, 25, 27, 30, 31] 
 
Conclusion 
A hypothetical protein may have a yet, uncharacterized role in a biological context or 
simply be the predicted result of a pseudogene and with no biological relevance.  In 
order to screen a dataset of hypothetical proteins, we propose a simple selection 
strategy where proteins are selected on the basis of well-characterized targeting 
peptides and protein domains. We have utilized a database of hypothetical proteins 
dating from 2006 and reviewed their annotated status in 2008. Accordingly, we can 
verify our selection strategy by reviewing the proteins that were hypothetical in 2006, 
but have been experimentally characterized by November 2008.  We chose to screen 
for hypothetical proteins predicted to be mitochondrial since considerable amounts of 
work have been performed within the last couple of years to build extensive databases 
of the human mitochondrial proteome, summarized in works like MitoCarta. From the 
2006 dataset, 5860 hypothetical proteins were identified, and from this dataset, we 
identified 100 proteins that we believe, have a high probability of being expressed 
mitochondrial proteins, based on our selection strategy. This list is not exhaustive as, 
for instance, hypothetical proteins with mitochondrial internal targeting signals but no 
mitochondrial presequence, were not considered. When compared to the 2008 dataset, 
we found that 53 of the 100 hypothetical proteins predicted to be mitochondrial have 
now been characterized, and 45% of those were found to be mitochondrial. In 
comparison, only 6% of the characterized proteins from the 2006 dataset have been 
categorized as mitochondrial in the same time period. Increasing the selectivity of 
TargetP increases the incidence of characterized mitochondrial proteins to 85%, but 
unfortunately decreases the total number of mitochondrial proteins identified. 
 
Investigating identified protein domains of 6 of the 36 hypothetical proteins predicted 
to be mitochondrial, we found a subset of 4 proteins having a strong mitochondrial 
signature in their identified protein domains. It is our opinion that these proteins are 
very interesting candidates for further experimental characterizations. 
In present work we have applied our selection strategy in the search for human 
mitochondrial proteins. From the characterized proteins we were able to verify the 
fidelity of our in silico selection strategy. The strategy is general and can be used to 
identify hypothetical proteins with a high probability of having a role in any organelle 
compartment where the internal targeting signals are characterized. Furthermore, 
many of the targeting signals and identifiable protein domains that are valid in human 
cells, are also valid in other eukaryotes. Our selection strategy can therefore be 
applied on a wide array of organisms. 
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Table 1. Predicted subcellular distribution of human hypothetical proteins, from the 
2006 and 2008 datasets. pTarget was used to predict the subcellular localization of 




Predicted subcellular distribution 
2006 dataset (5860 proteins) 
Predicted subcellular distribution 
2008 dataset of hypothetical 
proteins (1455 proteins) 
Nucleus 37 % 36 % 
Cytoplasm 13 % 14 % 
Plasma membrane 12 % 8 % 
Lysosomes 9 % 9 % 
Golgi 9 % 11 % 
Peroxysomes 7 % 10 % 
Extracellular/Secretory 6 % 4 % 
Mitochondria 5 % 5 % 
Endoplasmic reticulum 2 % 3 % 
 
Table 2. A selection of subcellular localization prediction programs for eukaryotic 
proteins. Listed are the numbers of compartments each program can predict targeting 






























Table 3: Hypothetical proteins from the 2006 dataset sorted into groups depending on 
the probability of having a mitochondrial N-terminal presequence localization signal. 
Proteins of Group I, have been predicted by TargetP to belong to reliability class 1, 
indicating the strongest prediction. Proteins of Group II contains proteins belonging to 
reliability class 1 and 2, while proteins of Group III contains proteins belonging to 
reliability class 1, 2 and 3. All proteins of Group I, II and III have identifiable protein 
domains according to SMART. The three groups have been compared with all 5860 
proteins of the 2006 dataset, and with their respective 2008 annotations, to evaluate 



















(6 of 20) 
65% 
(13 of 20) 
5% 
(1 of 20) 
85% 
(11 of 13) 
II 56 
27% 
(15 of 56) 
64% 
(36 of 56) 
9% 
(5 of 56) 
58% 
(21 of 36) 
III 100 
36% 
(36 of 100) 
53% 
(53 of 100) 
11% 
(11 of 100) 
45% 





(1455 of 5860) 
21% 
(1215 of 5860) 
54% 
(3190 of 5860) 
6% 
(67 of 1214) 
 
Table 4. Description of protein domains identified in 6 hypothetical proteins of Group 
I, predicted to be expressed and to have a role in a mitochondrial context. In 4 out of 6 
proteins, the identified protein domains have been described in experimentally 
characterized proteins of the mitochondria (First 4 domains). 
 
 




This hypothetical protein contains a Complex-1-LYR domain. The 
domain is present in a family of proteins, which include mitochondrial 
proteins from NADH-ubiquinone oxidoreductase complex 1. The 
domain is also present in the Saccharomyces cerevisiae protein Isd11, 
which is located in the mitochondrial matrix associated with the inner 
membrane. Isd11 protein is a subunit of the mitochondrial Fe/S protein 





Methyltransferase 12 domain is present in proteins, which actively 
transfer methyl from ubiguitous S-adenosyl-L-methionine (SAM) to 
nitrogen, oxygen or carbon. This methyltrasferase domain is found in a 
variety of SAM-dependent methyltransferases including Coq3 
methyltransferase, which is a mitochondrial protein involved in 





Sel1 like repeats are tetratricopeptide repeats (TPR) identified in LIN-12 
proteins of Caenorhabditis elegans as a negative regulator of the Notch 
pathway   [24] TPR-repeats are found in a variety of proteins including 
eukaryotic chaperone complexes involving HSP70 and HSP90, and 
TPRs are also present in the mitochondrial Tom70 import receptor [30, 
31] 
EAW75090 DUF1640 
DUF1640 domain is found in proteins of unknown functions.  In 
Saccharomyces cerevisiae a protein containing the domain is named 
FMP32 (Found in mitochondrial proteome protein 32) and was localized 





DUF143 : This domain has no known function and is found in the iojap 





Trm112p is a zinc finger domain found in the TRM112 protein that is 
required for tRNA methylation in Saccharomyces cerevisae. [33] 
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Protein entries of the 2006 and 2008 dataset. File is viewed with Excel or compatible 
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a b s t r a c t
Polycyclic aromatic hydrocarbons (PAHs) are environmental pollutants, formed during incomplete burn-
ing of coal, oil and gas. Several PAHs have carcinogenic and mutagenic potencies, but these compounds
must be activated in order to exert their mutagenic effects. One of the principal pathways proposed
for metabolic activation of PAHs involves the cytochrome P450 enzymes. The DNA damaging potential
of cytochrome P450-activated PAHs is generally associated with their bay and fjord regions, and the
DNA repair response of PAHs containing such regions has been thoroughly studied. However, little is
known about the repair of DNA damage resulting from metabolites from PAHs without bay and fjorday and fjord regions
NA repair pathways
regions. We have investigated the six-ringed PAH anthanthrene (dibenzo[def,mno]chrysene), which does
not posses bay or fjord motifs. We analyzed the repair profile of human cell extracts and of cell cul-
tures in response to DNA damage induced by cytochrome P450-activated anthanthrene. In cell extracts,
functional nucleotide excision repair (NER) and mismatch repair (MMR) activities were necessary to trig-
ger a response to anthanthrene metabolite-induced DNA damage. In cell cultures, NER was responsible













inactivated, a residual rep
. Introduction
Polycyclic aromatic hydrocarbons (PAHs) consist of a large group
f environmental pollutants, produced primarily by incomplete
ombustion of organic material, including burning of fossil fuels
nd tobacco. There are three principal pathways for metabolic acti-
ation of PAHs: the formation of PAH-o-quinones by dihydrodiol
ehydrogenase-catalyzed oxidation, the formation of a PAH radi-
al cation in a metabolic oxidation process involving cytochrome
450 peroxidase and finally the creation of dihydrodiol epoxides,
atalyzed by cytochrome P450 enzymes. Of the three pathways,
he latter is believed to be the dominant mechanism of chemical
arcinogenesis of PAHs, while the formation of PAH radical cations
s believed only to constitute a very small fraction of metabolites
ormed in vivo (reviewed in [1]). The formation of dihydrodiol epox-
des is associated with the structure motives referred to as bay and
Abbreviations: PAHs, polycyclic aromatic hydrocarbons; NER, nucleotide exci-
ion repair; MMR, mismatch repair; BER, base excision repair; GGR, global genomic
epair; TCR, transcription coupled repair; AP, apurinic; XPA, xeroderma pigmento-
um complementation group A; XPC, xeroderma pigmentosum complementation
roup C.
∗ Corresponding author. Tel.: +45 46742728; fax: +45 46743011.
E-mail address: ljr@ruc.dk (L.J. Rasmussen).
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jord regions (Fig. 1). These motives are believed to sterically hinder
poxide hydrolase that normally removes epoxides. Bay and fjord
egions, therefore, facilitate the creation of metabolites that are able
eact with DNA, creating bulky adducts [2]. In human cells, these
ypes of DNA damage are presumed to be repaired by nucleotide
xcision repair (NER) and to a lesser extend, base excision repair
BER) [3–6]. The formation of PAH-o-quinones is capable of gener-
ting reactive oxidative species, which in turn are able to result in
xidative DNA damage [1].
The DNA damaging potential of metabolites from PAHs without
ay and fjord regions has been reported [3], but little is known
bout the repair of the DNA damage resulting from metabolites
f this particular group of PAHs. The six-ringed PAH anthanthrene
dibenzo[def,mno]chrysene) is a PAH without bay or fjord regions.
he compound has been demonstrated to be a strong carcinogen
n mouse skin [7].
According to the three principal pathways for metabolic activa-
ion of PAHs, the DNA damaging potential of a PAH without bay and
jord regions is more likely to be related to oxidative DNA damage
han the creation of bulky adducts.Research by Platt et al. has resulted in a detailed model for
etabolic activation of anthanthrene and resulting derivatives with
utagenic potential [8]. Phenol derivatives were produced in the
etabolization process, and anthanthrene metabolites were sug-
ested to create stable radical species that could cause production






























































































Fig. 1. Illustration of bay and fjord regions in, respectively, chrysene and
f reactive species in the cell, in turn causing alkylation of DNA
nd oxidative DNA damage [8,9]. Recently the same group reported
hat the genotoxicity of anthanthrene metabolites and other PAHs
ere only detectable when V79 hamster cells were treated with
ydroxyurea and 1--d-arabinofuranoside [10].
The NER pathway recognizes DNA lesions that cause structural
eformation of the DNA helix. Bulky adducts are, therefore, gener-
lly considered to be repaired by NER. Following recognition, dual
ndonucleolytic incision around the site of the lesion is performed,
5–32 nucleotides of the damaged strand of DNA are excised and
he strand is resynthesized and ligated [11–13]. The NER pathway
s divided into two sub-pathways: global genomic repair (GGR),
hich repairs both transcribed and non-transcribed regions, and
ranscription coupled repair (TCR), which only acts on transcribed
equences after RNA polymerase II stalling [14]. The NER pathway is
omplex, requiring more than 20 different proteins, including sev-
ral of the xeroderma pigmentosum (XP) complementation groups.
n this article, we utilize two NER-deficient cell lines expressing
efective XPC or XPA proteins (xeroderma pigmentosum groups C
nd A), respectively. XPC is involved in the GGR sub-pathway, where
t functions in a complex that binds to the DNA lesion leading to
ending of DNA, facilitating downstream NER activity. Thus, the
PC mutant is GGR-deficient but TCR-proficient. XPA is involved in
erifying the initial damage recognition triggering the excision of
he damaged strand of DNA. This process is identical for both GGR
nd TCR and the XPA mutant is, therefore, GGR- and TCR-deficient.
Due to the formation of bulky adducts, NER is considered the
ain repair pathway involved in repair of DNA damage caused by
AHs. However, BER has been implicated in repair of DNA damage
nduced by PAHs, in competition with NER [5]. The BER pathway
eals with smaller damage to individual bases, such as oxidation,
ethylation, depurination, and deamination [15]. The BER path-
ay is initiated by DNA glycosylases that are capable of recognizing
nd removing particular subsets of base alterations by creating an
purinic (AP) site [16]. After DNA glycosylase activity, the resulting
P site must be processed by an AP endonuclease in order to gen-
rate a free 3′-OH terminus allowing insertion of a nucleotide and
igation of the strand.
With the suggestion of anthanthrene metabolites creating PAH-
-quinones and thereby produce reactive oxygen species [7,8],
ismatch repair (MMR) must also be considered when analyzing
he nature of repair of PAHs without bay and fjord regions. MMR
s a post-replicative repair system, which corrects strand-specific
ase mispairs and small loop structures [16–19]. MMR also recog-
izes smaller base analogous as mispairs, which gives the repair
ystem a role in the repair of oxidative DNA damage, thus making
he system a candidate for repair of PAH-mediated DNA damage
20]. MMR is initiated by the binding of mismatch recognizing
omplexes to base–base mismatches and insertion/deletion loops.
ollowing initiation, the newly synthesized strand is removed by
xonuclease activity. Strand discrimination is signaled by a nick
ocated either 3′ or 5′ to the mismatch [21] and it has been suggested
hat gaps between individual Okazaki fragments serve as the strand
2
t
o[c]phenanthrene together with anthanthrene without either regions.
iscriminating signal [22]. Finally, the strand is resynthesized and
igated.
In this work, we have used hMLH1-deficient cells to study
he cellular response of MMR-deficiency on anthanthrene-induced
NA damage. The hMLH1 protein is essential for initiation of MMR,
nd cells deficient in hMLH1 activity are MMR-deficient.
As mentioned previously, anthanthrene is a PAH without bay
r fjord regions. With the mutagenic derivatives of anthanthrene
escribed by Platt et al. [8], we aimed to characterize the repair
athways responsible for repairing DNA damage caused by PAH.
NA damage induced by anthanthrene metabolites have recently
een reported to only be detectable when dNTP synthesis was
nhibited with hydroxyurea and cytosine 1--d-arabinofuranoside.
y inhibiting the dNTP synthesis, the final step of NER, the resyn-
hesis of the excised damaged DNA strand, is indirectly inhibited,
eaving nicks in the DNA quantifiable by comet assay. However, inhi-
ition of dNTP synthesis also inhibits the final step of MMR, which
lso leave nicks in the DNA. Furthermore, inhibition of dNTP syn-
hesis can induce DNA strand breaks by stalling of replication fork,
hich in turn will induce other repair mechanisms [23].
We investigated DNA repair of PAH-induced damage in extracts
f human cell lines with different repair status. We hypothesize
hat DNA damage induced by anthanthrene metabolites is repaired
y both NER and an unidentified repair pathway. The NER pathway
as higher affinity for PAH-induced DNA damage but when the NER
athway is inactivated, the unidentified repair pathway is able to
erform a faster repair than the NER pathway.
. Materials and methods
.1. Cell cultures
Human fibroblast cell lines SV40-transformed “wild type” (cat-
logue number AG07217), SV40-transformed XPA−/− (catalogue
umber GM04429F) and SV40-transformed XPC−/− (catalogue
umber GM16093) were purchased from Coriell Cell Repositories
United States) and maintained in Dulbecco’s MEM1 media supple-
ented with Glutamax (Invitrogen, Gibco), 10% fetal bovine serum
FBS) (Biochrom KG), and 1% penicillin/streptomycin (Invitrogen,
ibco). Human colon carcinoma cell lines HCT116 (hMLH1−/−)
nd HCT116chr3 (hMLH1+) [24] were maintained in McCoy’s
A media supplemented with Glutamax (Invitrogen, Gibco), 10%
BS (BioChrom AG), and 1% penicillin/streptomycin (Invitrogen,
ibco). HCT116chr3 cells were also supplemented with 400 g/mL
eneticin (G418) (Invitrogen, Gibco). Cells were grown at 37 ◦C
n a humidified atmosphere containing 5% CO2. Throughout the
emaining article, the cell lines obtained from Coriell Cell Reposi-
ories will be referred to by their catalogue numbers for simplicity,
hile the HCT116 strains will be referred to directly..2. Cell survival following UV-radiation
Cells from exponentially growing cultures were seeded at densi-














































































































14 C. Desler et al. / Chemico-Biolog
ttach for 18 h. After initial incubation the media was removed and
ells were exposed to UV-radiation ranging from 0 to 25 J/m2 under
254-nm germicidal UV lamp. After radiation growth media was
dded to the culture flasks and cells were grown for 9 days, with
hange of growth media every 2–3 days. The cell culture plates
ere washed with PBS (Gibco BRL, Life Technologies) and dried
t room temperature for 12–24 h. Cells were stained with a mix-
ure of 5% Giesma (Merck) and 50% methanol for 60 min and rinsed
ith water. Colonies were examined and counted using a stereo
agnifier (Olympus SZ-ST).
.3. Preparation of whole cell extracts for DNA repair assays
Cell-free extracts were prepared as described in [25]. In brief,
ells were pelleted and resuspended in ice cold isotonic buffer
20 mM Hepes, pH 7.9, 5 mM KCl, 1.5 mM MgCl2, 1 mM DTT, 0.1 mM
MSF, and 250 mM sucrose) and centrifuged at 750 × g for 4 min
t 4 ◦C. Cells were washed in ice cold hypotonic buffer (20 mM
epes, pH 7.9, 5 mM KCl, 1.5 mM MgCl2, 1 mM DTT, and 0.1 mM
MSF), and resuspended in ice cold hypotonic buffer to a cell den-
ity of approximately 1 × 108 cells/mL. Cells were allowed to swell
or 15 min on ice and were subsequently homogenized with a
inimum of four strokes of a sterile A-pestle (Kontes) followed
y microscopical examination. Homogenizing was repeated until
pproximately 85% of the cells showed signs of membrane degra-
ation. After homogenization, suspensions were incubated 30 min
n ice. Suspensions were centrifuged at 2000 × g for 10 min at 4 ◦C,
nd the supernatants were centrifuged at 12,000 × g for 10 min at
◦C. The supernatants were collected in a single tube and mixed
arefully to ensure homogeneity. Protein concentration of extracts
as determined by BioRad Protein Assay (BioRad) using BSA as
tandard.
.4. Activation of anthanthrene
Anthanthrene was metabolized using a cytochrome P450 sys-
em extracted from male Sprague–Dawley rat liver as microsomes
BD Gentest). Microsomes were diluted to a 0.2-mg/mL concen-
ration in Dulbecco’s PBS solution for cell-free DNA assays or in
ulbecco’s MEM1 media with Glutamax or McCoy’s 5A media
ith Glutamax for cell culture assays. Microsomes were supple-
ented with a NADPH regenerating system consisting of 1.3 mM
ADP+, 3.3 mM glucose-6-phosphate, 3.3 mM MgCl2 and 0.4 U/mL
lucose-6-phosphate dehydrogenase (BD Gentest). The metabo-
izing system was preincubated 5 min in a shaking water bath at
7 ◦C in the dark. After preincubation, anthanthrene (Fluka, 99%) in
MSO was added to a final concentration of 16 M. The solution
as incubated 100 min with shaking in a water bath at 37 ◦C in the
ark. Mock solution was prepared as described above, but without
nthanthrene.
.5. Analysis of DNA damage and repair by human cell extracts
The pcDNA3.1 (Invitrogen) and pcDNA3.1-lacZ (Invitrogen) plas-
ids were purified from Escherichia coli DH10B using Qiagen high
peed plasmid maxi-prep kit according to manufacturers instruc-
ions. The quality of the purified plasmids was controlled by
isualization on a 0.7% agarose gel and plasmid concentration
etermined by Abs260 photometric scanning in a Genequant pho-
ometer (Pharmacia). 5 g pcDNA3.1 plasmid DNA was incubated
n a 100-L solution containing TE buffer, 20% ethanol and various
oncentrations of native or metabolized anthanthrene, resulting in
nal anthanthrene concentrations of 0.3, 3.0 and 5.0 M. All sam-
les were incubated for 2.5 h with shaking in a thermostated water
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recipitated according to standard methods and resuspended in TE
uffer to a final concentration of 500 ng/L DNA.
Repair reactions were prepared as described in [25]. 500 ng
f pcDNA3.1-lacZ and pcDNA3.1 treated with either native
nthanthrene, anthanthrene metabolites or UV light from a 254-nm
ermicidal UV lamp (400 J/m2), were incubated with 140 g pro-
ein extract in a total volume of 75 L (30 mM Hepes (pH 7.8), 7 mM
gCl2, 4 mM ATP, 200 M CTP, GTP and UTP, 100 M dATP, dGTP,
TTP and dCTP and 15 nM [-32P] dCTP (3000 Ci/mmol), 40 mM
reatine phosphate, 100 g/mL creatine phosphokinase, 15 mM
odium phosphate (pH 7.5)). The repair reactions were incubated
0 min at 37 ◦C. The reactions were terminated by adding Proteinase
(2 mg/mL), SDS (2 vol.%), and EDTA (50 mM, pH 8.0) and incubated
or 30 min at 37 ◦C.
Plasmid DNA was extracted from the repair reaction mix using
henol extraction and ethanol precipitation according to standard
ethods. The plasmids were digested with BamHI and fragments
isualized and quantified on a 1% agarose gel. The gel was dried in
BioRad 583 slap drier (BioRad) and placed on a PhosphorImag-
ng screen (Amersham). The PhosphorImaging screen was analyzed
sing a STORM 840 scanner (Molecular Dynamics, Amersham), and
he visible phosphorescence bands were analyzed with Imagemas-
er Total-lab software (Molecular Dynamics, Amersham). Measured
mount of incorporated radioactivity was normalized to quantity
f DNA.
.6. Analysis of DNA damage and repair in cell cultures
1.5 × 105 cells were plated in 2 mL cell culture dishes (Nunc) 2
ays prior to the experiment. Anthanthrene was metabolized as
escribed earlier. Cells were incubated at 37 ◦C in a humidified
tmosphere containing 5% CO2 for 2.5 h in growth medium contain-
ng either 0 M or 16.1 M metabolized anthanthrene. Following
ncubation, cells were washed twice with PBS (Invitrogen, Gibco),
nd immediately processed for comet assay or incubated in growth
edia for either 30 min, 2.5 h or 14 h at 37 ◦C and 5% CO2 to allow
epair before being processed for comet assay.
.7. Comet assay
A modified version [26] of single-cell gel electrophoresis was
sed to analyze DNA damage and repair. Twenty-five micro-
iters of the prepared cell suspensions were mixed with 225 L
olten (42 ◦C) 0.75% LMP agarose (GibcoBRL, Life Technologies),
nd 180 L of the resulting mixture was immediately cast on
he hydrophilic side of 85 mm × 100 mm GelBond film (Medinova
cientific, Hellerup, Denmark), using chambers from Lab-Tek II
hamber Slides (Nunc, Life Technologies) as molds. The gels were
ooled for approximately 10 min at 4 ◦C in the dark and the Lab-Tek
I chambers removed. The gels were submersed in cold lysis buffer
2.5 M NaCl, 10 mM Tris-Base, 100 mM EDTA-Na2, 1% Na-sarcosinat,
0% DMSO, 1% Triton X-100, pH 10) for 60 min, carefully washed
hree times with millipore water, and submersed in electrophore-
is buffer (0.3 M NaOH, 1 mM EDTA-Na2, pH 13.2) for 40 min before
lectrophoresis for 20 min at 300 mA and 25 V. After electrophore-
is, samples were submerged twice in neutralization buffer (0.4 M
ris, pH 7.5) for 5 min and washed once with sterile water before
hey were fixed in 96% ethanol for approximately 90 min. The gels
ere air-dried overnight, dyed with SYBR Gold (Bie and Berntsen,
ødovre, Denmark), and analyzed under a fluorescence microscope
Dialux 22EB (Leica) microscope, Switzerland). From each gel, pic-
ures were taken of randomly selected cells and were analyzed
sing Comet Assay III (Perceptive instruments) software to calcu-
ate comet tail moment. Mean tail moment was calculated from
he comet tail moment of 50 randomly selected cells and each data
C. Desler et al. / Chemico-Biological In
Table 1
Description of cell lines used. (+) Annotates proficiency and (−) deficiency.
Cell line GGR status TCR status MMR status










































































M04429F − − +
M16093 − + +
CT116chr3 + + +
CT116 + + −
oint consists of a triplicate of mean tail moments. This value was
sed as a quantitative index of single and double stranded DNA
reaks. The statistical analysis was performed using Student’s t-
est. The differences between data sets were considered significant
t p-values <0.05.
. Results
We used five different human cell lines to characterize DNA
epair activity caused by anthanthrene metabolites (Table 1):
G07217 (NER- and MMR-proficient), GM04429F (XPA- and
ER-deficient), GM16093 (XPC- and GGR-deficient), HCT116
MMR-deficient), and HCT116chr3 (NER- and MMR-proficient).
he repair defects of the cell lines were confirmed by sensitivity
o UV-radiation (NER) and resistance to N-methyl-N′-nitro-N-
itrosoguanidine (MNNG) (MMR) [27] (data not shown).
.1. Post-labeling assay of plasmids exposed to anthanthrene
etabolites
In order to characterize DNA repair activities associated with
NA damage induced by anthanthrene metabolites, we measured
he incorporation of [-32P] dCTP into a well-defined DNA substrate
n a post-labeling assay. Damaged plasmid DNA was incubated
ith [-32P] dCTP and cell extracts from repair-deficient as well
s proficient cell lines. The amount of incorporated [-32P] dCTP
s an indicator of repair activity in the cell extracts, in the form of
xcision and resynthesis of DNA (Fig. 2). Our results suggest that
lasmid DNA incubated with anthanthrene metabolites demon-
trates increased incorporation of [-32P] dCTP into DNA when
ncubated with AG07217 NER-proficient cell extracts. The incor-
oration of [-32P] dCTP is proportional to the concentration
f anthanthrene metabolites, and in AG07217 NER-proficient cell
ig. 2. Dose–response curves plotting normalized level of repair as a function of
nthanthrene concentration of AG07217 extracts acting on DNA incubated with
nthanthrene metabolites ( ) or native anthanthrene (), GM04429F (), GM16093
), HCT116 (), and HCT116chr3 (♦) extracts acting on DNA incubated with
nthanthrene metabolites (n = 3). The value of each point in the response curves
hows the ratio between the amount of linear plasmid DNA isolated from each
epair action (from ethidium bromide staining of the agarose gel) and incorpo-
ated labeled dCTP (from phosphoimaging), and subsequently normalizing these
alues with respect to incorporation of dCTP in repair reactions with anthanthrene
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xtracts, the activity of repair is, therefore, correlated to the con-
entration of anthanthrene metabolites (Fig. 2). Incubating plasmid
NA with native anthanthrene, in AG07217 NER-proficient cell
xtracts, did not induce a significant incorporation of the radioac-
ive nucleotide. This indicates that activation of anthanthrene
s necessary to induce DNA damage in this experimental
ystem.
The cell extract of the GM04429F XPA-deficient cell line, showed
ecreased incorporation of [-32P] dCTP compared to AG07217
ER-proficient cell extracts, indicating reduced repair activity, as
xpected from the NER-deficient status of this cell line. We did
easure some [-32P] dCTP incorporation at 5 M anthanthrene
etabolites, suggesting that either a residual NER repair activity
s present, or that other repair mechanisms are initiating repair of
nthanthrene-induced DNA damage when NER is inhibited. Inter-
stingly, repair activity of the cell extract of the GGR-defective cell
ine GM16093 that does not express a functional XPC protein, is
ot significantly different from the response curve of AG07217 cell
xtract.
Fig. 2 shows that the repair response measured in MMR-
eficient HCT116 cell extracts is lower than in the MMR-proficient
CT116chr3 cell extracts. The repair activity in HCT116chr3 cell
xtracts is comparable to the repair response of AG07217 wildtype
xtract suggesting that MMR is involved in repair of DNA damage
aused by anthanthrene.
.2. Comet assays of cell cultures exposed to anthanthrene
etabolites
In order to investigate the effect of metabolized anthanthrene in
ell cultures, we used the comet assay to determine the occurrence
f DNA breaks after treatment with metabolized anthanthrene.
e assayed the NER-proficient cell line AG07217 and the XPA-
nd XPC-deficient cell lines GM04429F and GM16093 immedi-
tely after treatment with metabolized anthanthrene as well as
0 min, 2.5 and 14 h after treatment to allow DNA repair. The MMR-
roficient and MMR-deficient cell lines HCT116chr3 and HCT116
here only investigated immediately after treatment with metab-
lized anthanthrene and 2.5 h after treatment (Fig. 3). Our results
howed that regardless of repair status metabolized anthanthrene-
nduced DNA damage in form of DNA breaks when compared
o mock treated cells. The increase of DNA damage immediate
fter anthanthrene treatment is most prominent in HCT116chr3,
G07217 NER-proficient and GM16093 XPC-deficient cell lines with
n 8–12-fold increase in DNA breaks. After treatment with metab-
lized anthanthrene, the NER-proficient cell line AG07217 and the
PA- and XPC-deficient cell lines GM04429F and GM16093 were
llowed to repair for 14 h. After 30 min of repair, a significant
.5-fold decrease in levels of DNA damage was found for the XPC-
eficient cell line GM16093 (p < 0.05). No significant decrease was
ound for the NER-proficient cell line AG07217 or the XPA-deficient
ell line GM04429F. After 2.5 h of repair, the two NER mutants
M04429F and GM16093 displayed, respectively, a 1.8- and 1.7-fold
urther decrease of the levels of DNA damage in form of DNA breaks
p < 0.05 for GM04429F and p < 0.01 for GM16093). For the NER-
roficient cell line AG07217, no significant difference was found
etween the levels of DNA damage in cells immediately after treat-
ent with metabolized anthanthrene and after 30 min and 2.5 h of
epair. After 14 h of repair, the level of DNA damage was reduced
o the level of mock treated cells for all investigated cell lines. This
ndicates that the NER functional cell lines are unable to perform
epair as fast as the NER mutants.
For the MMR-deficient (HCT116) and the corresponding MMR-
roficient (HCT116chr3) cell lines 2.5 h of repair did not alter the
ccurrence of DNA breaks significantly indicating that the cell lines
216 C. Desler et al. / Chemico-Biological Interactions 177 (2009) 212–217
Fig. 3. Comet assay of AG07217 (NER- and MMR-proficient), GM04429F (XPC−/− , NER-deficient), GM16093 (XPC−/− , GGR-deficient), HCT116chr3 (NER- and MMR-proficient)














































































nd HCT116 (hMLH1, NER-proficient and MMR-deficient) cell lines, 0 h (white bar
ither treated with anthanthrene in metabolizing system (treated) or metabolizing s
oment (n = 3). (*) Denotes significant difference. The statistical analysis was perfo
re incapable or inefficient in repair of the DNA damage caused by
nthanthrene metabolites within this timeframe.
. Discussion
We have examined the nature of DNA repair pathways activated
y anthanthrene metabolites in human cell extracts and in cell
ultures using cell lines with different repair status. Our results
onfirm that anthanthrene has a DNA damaging effect on human
ells, despite its lack of bay and fjord regions. We also show that,
nthanthrene metabolites induce DNA damage that activates the
ER pathway in both cell cultures and cell extracts, and impli-
ate the MMR pathway in cell extracts. In post-labeling assays,
ell extract of the NER-deficient GM04429 XPA-deficient mutant
isplayed decreased DNA repair, measured by incorporation of [-
2P] dCTP, when compared to the NER repair-proficient AG07217
ell line. The XPA protein identifies NER lesions and recognizes
arious NER-specific types of damage. The protein is important in
ositioning the repair machinery correctly around the DNA lesion
28]. The XPA protein is, therefore, essential for the initiation of
oth the GGR and TCR sub-pathways of NER. Our results using cell
xtracts clearly indicate the involvement of the NER pathway in
epairing DNA damage caused by anthanthrene metabolites. This
s in accordance with results from other groups [9]. Since DNA
elix distortions are the main substrates for the NER, our results
ndicate that anthanthrene metabolites can result in bulky adducts
espite the lack of bay and fjord regions. In post-labeling assays,
o difference in DNA repair was measured between XPC-deficient
M16093 and the NER-proficient AG07217 cell lines. The XPC pro-
ein is not essential for TCR and is only involved in GGR [29].
his indicates that in cell extracts, this particular pathway of NER
s not involved in repair of DNA damage caused by metabolized
nthanthrene.
Using the comet assay, we show that the NER-proficient cell
ines AG07217, HCT116 and HCT116chr3 are unable to reduce the
ccurrence of DNA breaks over a period of 2.5 h, while the NER-
eficient cell lines GM04429 and GM16093 were able to decrease
he occurrence of DNA damage by, respectively, 2.8- and 4.2-fold in
he same period of time. Furthermore, the XPC-deficient cell line
M16093 was able to decrease the levels of DNA damage in the
orm of DNA breaks already after 30 min of repair. This indicates
hat a functional NER delays the repair of DNA damage result-
ng from anthanthrene metabolites in cell cultures. It has been
r
C
in (black bar), 2.5 h (striped bar) and 14 h (grey bar) after treatment. Cells were
alone as a control (mock) (see Section 2). DNA damage was measured as mean tail
using Student’s t-test. A difference at p < 0.05 was considered significant.
eported how two different repair systems can compete for the
ame substrate with the result of the slower repair pathway pre-
ominating [30]. We hypothesize that DNA damage induced by
nthanthrene metabolites are subject for repair by both NER and
n unidentified repair pathway, where NER has a higher affinity
or the damage. When the NER pathway is impaired, the unidenti-
ed repair pathway is able to perform a faster repair than the NER
athway.
Of the investigated cell lines, the XPC-deficient cell line had the
ighest occurrence of DNA breaks measured by comet assay imme-
iately after treatment with anthanthrene metabolites. Compared
o mock treated cells, the XPC-deficient GM16093 cell line had a
2-fold higher occurrence of DNA breaks following anthanthrene
etabolite treatment. The higher occurrence of DNA breaks can
e cell specific; however, the XPC protein was recently shown to
e implicated in the BER pathway in response to oxidative dam-
ge [31]. It was found that XPC stimulates the activation of the
pecific DNA glycosylase OGG1 in response to oxidative damage.
lycosylases recognize and incise individual damaged bases leav-
ng abasic sites transformed to a ligatable nick by AP endonucleases.
ith the XPC-deficient GM16093 cell line, the stimulation of OGG1
ould be absent, leading to a potentially slower activation of the
ER pathway.
Although the primary function of MMR is to repair DNA repli-
ation errors its involvement in cellular responses to a variety of
hemotherapeutic drugs has been demonstrated. [32]. As found by
latt and co-workers [7], a portion of the anthanthrene metabolites
as oxidative properties. Even though Platt et al. did not propose
hat this sub-group of anthanthrene metabolites was responsible
or the main mutagenic effect, it is possible that these oxidation
roducts can cause DNA damage in the form of lesser DNA-base
nalogues, which is recognizable by MMR proteins as mismatches.
e show that the absence of functional hMLH1 decreases the repair
esponse in cell extracts. The same trend was not evident with cul-
ured cells treated with metabolized anthanthrene. This indicates
hat the mutagenic effect of activated anthanthrene is more likely
o be related to the formation of bulky adducts than the forma-
ion of oxidative DNA damage, despite the lack of bay and fjord
egions.
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